# EDGAR Filing Document

**Accession Number:** 0001173489
**File Stem:** 0001437749-25-034103
**Filing Date:** 2025-11
**Character Count:** 162655
**Document Hash:** 59e59083723c059d39c132cb8d8d6483
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-25-034103.hdr.sgml**: 20251110

**ACCESSION NUMBER**: 0001437749-25-034103

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 86

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20251110

**DATE AS OF CHANGE**: 20251110

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CEVA INC
- **CENTRAL INDEX KEY:** 0001173489
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 770556376
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-49842
- **FILM NUMBER:** 251466449

**BUSINESS ADDRESS:**
- **STREET 1:** 15245 SHADY GROVE ROAD
- **STREET 2:** SUITE 400
- **CITY:** ROCKVILLE
- **STATE:** MD
- **ZIP:** 20850
- **BUSINESS PHONE:** 240-308-8328

**MAIL ADDRESS:**
- **STREET 1:** 15245 SHADY GROVE ROAD
- **STREET 2:** SUITE 400
- **CITY:** ROCKVILLE
- **STATE:** MD
- **ZIP:** 20850

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CEVA  INC
- **DATE OF NAME CHANGE:** 20031208

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PARTHUSCEVA INC
- **DATE OF NAME CHANGE:** 20021101

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CEVA INC
- **DATE OF NAME CHANGE:** 20020515

?xml version='1.0' encoding='ASCII'? ceva20250930_10q.htm

[**Table of Contents**](#toc)

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

------

**FORM 10-Q**

**(Mark One)**

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.**

**For the quarterly period ended: September 30, 2025**<br>

**OR**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.**

**For the transition period from __________ to _____________**<br>

**Commission file number: 000-49842**

------

## Ceva, Inc.
**(Exact Name of Registrant as Specified in Its Charter)**

---

| | |
|:---|:---|
| **Delaware** | **77-0556376** |
| **(State or Other Jurisdiction of Incorporation or Organization)** | **(I.R.S. Employer Identification No.)** |
| **15245 Shady Grove Road, Suite 400, Rockville, MD 20850** | **20850** |
| **(Address of Principal Executive Offices)** | **(Zip Code)** |

---

**(240)-308-8328**

**(Registrant**'**s Telephone Number, Including Area Code)**

------

Securities registered pursuant to Section 12(b) of the Act

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common Stock, $.001 per share | CEVA | Nasdaq Global Market |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐

------

[**Table of Contents**](#toc)

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of "large accelerated filer", "accelerated filer", "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one).

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☐ | Accelerated filer | ☒ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| Emerging growth company | ☐ |  |  |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer's classes of common stock as of the latest practicable date: 24,017,805 of common stock, $0.001 par value, as of November 5, 2025.

------

[**Table of Contents**](#toc)

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
| | | **<u>Page</u>** |
| PART I. | [<u>FINANCIAL INFORMATION</u>](#parti) | [6](#parti) |
| Item 1. | [<u>Interim Condensed Consolidated Balance Sheets at September 30, 2025 (unaudited) and December 31, 2024</u>](#parti) | [6](#parti) |
|  | [<u>Interim Condensed Consolidated Statements of Loss (unaudited) for the three and nine months ended September 30, 2025 and 2024</u>](#sol) | [7](#sol) |
|  | [<u>Interim Condensed Consolidated Statements of Comprehensive Income (Loss) (unaudited) for the three and nine months ended September 30, 2025 and 2024</u>](#ci) | [8](#ci) |
|  | [<u>Interim Condensed Consolidated Statements of Changes in Stockholders</u><u>'</u> <u>Equity</u> <u>(unaudited) for the three and nine months ended September 30, 2025 and 2024</u>](#se) | [9](#se) |
|  | [<u>Interim Condensed Consolidated Statements of Cash Flows (unaudited) for the nine months ended September 30, 2025 and 2024</u>](#cf) | [11](#cf) |
|  | [<u>Notes to the Interim Condensed Consolidated Financial Statements</u>](#notes) | [12](#notes) |
| Item 2. | [<u>Management</u><u>'</u><u>s Discussion and Analysis of Financial Condition and Results of Operations</u>](#itemtwo) | [28](#itemtwo) |
| Item 3. | [<u>Quantitative and Qualitative Disclosures about Market Risk</u>](#itemthree) | [36](#itemthree) |
| Item 4. | [<u>Controls and Procedures</u>](#itemfour) | [37](#itemfour) |
| PART II.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;  | [<u>OTHER INFORMATION</u>](#partii) | [37](#partii) |
| Item 1.&nbsp;&nbsp;&nbsp;&nbsp; | [<u>Legal Proceedings</u>](#legal) | [37](#legal) |
| Item 1A. | [<u>Risk Factors</u>](#risk) | [38](#risk) |
| Item 2.  | [<u>Unregistered Sales of Equity Securities and Use of Proceeds</u>](#unregistered) | [39](#unregistered) |
| Item 3 | [<u>Defaults Upon Senior Securities</u>](#defaults) | [39](#defaults) |
| Item 4 | [<u>Mine Safety Disclosures</u>](#minesafety) | [39](#minesafety) |
| Item 5 | [<u>Other Information</u>](#otherinfo) | [39](#otherinfo) |
| Item 6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; | [<u>Exhibits</u>](#exhibits) | [40](#exhibits) |
| [<u>SIGNATURES</u>](#signatures) | [<u>SIGNATURES</u>](#signatures) | [40](#signatures) |

---

------

[**Table of Contents**](#toc)

**FORWARD-LOOKING STATEMENTS**

**FORWARD-LOOKING STATEMENTS AND INDUSTRY DATA**

This Quarterly Report contains forward-looking statements that involve risks and uncertainties, as well as assumptions that if they materialize or prove incorrect, could cause the results of Ceva to differ materially from those expressed or implied by such forward-looking statements and assumptions. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. Forward-looking statements are generally written in the future tense and/or are preceded by words such as "will," "may," "should," "could," "expect," "suggest," "believe," "anticipate," "intend," "plan," or other similar words. Forward-looking statements include the following:

● Our belief that we are the leader in silicon and software IP enabling Physical AI, and our view that Physical AI represents the natural evolution of Edge AI, unifying connectivity, sensing and inference to enable intelligent interaction between devices, the physical environment and the cloud, and that we are uniquely positioned as the only company with leadership in innovative silicon and software IP solutions across all three layers;

● Our belief that our technologies power the connectivity, perception, and intelligence in today's most advanced smart edge products across large, diversified markets covering the consumer Internet-of-Things (IoT), automotive, industrial and infrastructure, and mobile and personal computing (PC) markets, and that these sectors will represent a $170 billion total addressable market for Physical AI and Edge AI by 2030 based on our market research;

● Our belief that our portfolio of technologies comprised of connectivity, sensing and inference positions us at the center of the most important megatrends shaping the semiconductor industry, including 5G expansion, generative and embedded AI, industrial automation and vehicle electrification, and our belief that demand across these areas continues to drive strong interest in our IP portfolio, both in established markets and in new, emerging use cases;

● Our belief that our execution of licensing agreements for the NeuPro family of AI neural processing units (NPUs), our SensPro AI digital signal processors (DSPs) and our WiFi 7 and Bluetooth High Data Throughput IP reinforces our role as the enabler of Physical AI across consumer, automotive, industrial and infrastructure markets;

● Our belief that our Bluetooth, Wi-Fi, Ultra Wide Band (UWB) and cellular IoT IP allow us to address the high volume IoT industrial, consumer and smart home markets, and our expectation that the overall addressable market size for this IP will be more than 16.5 billion devices annually by 2029 based on research from ABI Research;

● Our belief that, with our leadership in Wi-Fi 6 and Wi-Fi 7 IP, we are positioned to capture higher royalty revenues as customers transition to newer standards;

● Our belief that our PentaG2 platform and DSPs for 5G mobile broadband and 5G RedCap, and our PentaG RAN platform for 5G RAN, including the Ceva-XC22 multi-thread DSP, are some of the industry's most comprehensive baseband IP solutions enabling fixed wireless access, satellite communications, robotics, automotive and industrial applications, and extend our leadership into 5G RAN and 5G Advanced for data centers and infrastructure enabling scalable, customizable solutions for next-generation networks;

● Our belief that the high-volume consumer audio markets, including True Wireless Stereo (TWS) earbuds, Augmented Reality (AR) and Virtual Reality (VR) headsets, and wearables represent incremental growth opportunities for our Bluetooth, Audio AI DSPs, NPUs and RealSpace Spatial Audio & Head Tracking software;

● Our belief that the combination of our MotionEngine software, SensPro DSPs and NeuPro NPUs positions us as a one-stop shop for sensor processing and AI-driven user experiences across robotics, smartphones, laptops, TWS earbuds and other connected devices;

● Our belief that our newest generation family of NeuPro-M AI NPUs present a highly efficient and high-performance architecture to enable generative and classic AI across devices from gateways and notebooks to AR/VR and smartphones;

● Our belief that our SensPro2 sensor hub AI DSP family can address the growing demand for efficient, high-performance AI signal processing across sensor-rich applications, from smartphones and drones to automotive ADAS and industrial IoT (IIoT);

● Statements regarding third-party estimates of industry growth and future market conditions, including research from Bloomberg Intelligence which forecasts that hardware revenue associated with computer vision AI products and conversational AI devices will reach $58 billion and $110 billion, respectively, by 2032, underscoring the scale of the market opportunity;

------

[**Table of Contents**](#toc)

● Our belief that our diversified royalty streams, spanning high-volume Bluetooth and Wi-Fi connectivity platforms, higher-value inference engines and AI DSPs such as NeuPro and SensPro, and infrastructure-class platforms like PentaG-RAN, together with our focus on silicon and software IP solutions across the connectivity, sensing and inference layers of Physical AI, position us for sustained, long-term growth in shipments and royalty revenues across consumer, automotive, industrial and infrastructure markets;

● Our belief that digital transformation is entering a new era defined by Physical AI, where intelligence is embedded directly into devices that connect, sense and interact with the real world, and that our ubiquitous technology, broad IP portfolio and collaborative licensing model position us to capture significant, secular growth as industries continue to become increasingly connected and intelligent;

● Any statements or guidance regarding sales trends and financial results for 2025 and other future periods, including our lowered revenue guidance for 2025, our expectations with respect to future customers, contracts, revenues and expenses, regarding our customer pipeline, that we expect our licensing and related revenues business will continue to expand as Physical AI adoption accelerates into new markets and use cases, particularly for IIoT and consumer IoT devices, that we expect our connectivity products to continue to show strength in royalties in 2025, our expectation that growth in royalties will continue through the rest of 2025, that we remain optimistic about the long-term potential of our royalty business supported by continued demand and steady market optimism, that a significant portion of our future revenues will continue to be generated by a limited number of customers in part due to consolidation in the semiconductor industry, that international customers will continue to account for a significant portion of our revenues for the foreseeable future, that an increasing portion of our new customers and revenues will be derived from international customers generally and sales to Asia Pacific in particular, and that we can expand our customer base and revenues in Europe and the U.S.;

● Our expectations around the impact of elevated geopolitical tensions, volatility and uncertainty with respect to international trade policies, including tariffs, export controls or other trade measures on our business, our customers, the markets in which we compete and the global economy overall;

● Our expectations around the impact of future changes in tax laws, regulations, or interpretations in the United States, Israel, France, Ireland, or other jurisdictions where we operate on our effective tax rate and overall tax expense, including the potential for increased withholding tax expenses and changes to preferential tax regimes;

● Our belief that our cash and cash equivalents, short-term bank deposits and marketable securities, along with cash from operations, will provide sufficient capital to fund our operations for at least the next 12 months; and

● Our belief that fluctuations in interest rates within our investment portfolio will not have a material effect on our financial position on an annual or quarterly basis.

Forward-looking statements are not guarantees of future performance and involve risks and uncertainties. The forward-looking statements contained in this report are based on information that is currently available to us and expectations and assumptions that we deem reasonable at the time the statements were made. We do not undertake any obligation to update any forward-looking statements in this report or in any of our other communications, except as required by law. All such forward-looking statements should be read as of the time the statements were made and with the recognition that these forward-looking statements may not be complete or accurate at a later date.

Many factors may cause actual results to differ materially from those expressed or implied by the forward-looking statements contained in this report. These factors include, but are not limited to, those risks set forth in Part II – Item 1A – "Risk Factors" of this Form 10-Q.

This report contains market data prepared by third party research firm. Actual market results may differ from their projections.

------

[**Table of Contents**](#toc)

**PART I. FINANCIAL INFORMATION**

**Item 1. FINANCIAL STATEMENTS**

**INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)**

------

**U.S. dollars in thousands, except share and per share data**

---

| | | |
|:---|:---|:---|
|  | **September 30,**<br> **2025** | **December 31,<br> 2024** |
| **ASSETS** |  |  |
| Current assets: |  |  |
| Cash and cash equivalents | $17270 | $18498 |
| Short-term bank deposits | 2807 | 2029 |
| Marketable securities | 131981 | 143117 |
| Trade receivables (net of allowance for credit losses of $2,626 at both September 30, 2025 and December 31, 2024) | 49699 | 37209 |
| Prepaid expenses and other current assets | 12649 | 15488 |
| Total current assets | 214406 | 216341 |
| Long-term assets: |  |  |
| Severance pay fund | 8021 | 7161 |
| Deferred tax assets, net | 1402 | 1456 |
| Property and equipment, net | 6008 | 6877 |
| Operating lease right-of-use assets | 3962 | 5811 |
| Goodwill | 58308 | 58308 |
| Intangible assets, net | 1252 | 1877 |
| Investments in marketable equity securities | 51 | 312 |
| Other long-term assets | 12604 | 10805 |
| Total long-term assets | 91608 | 92607 |
| Total assets | $306014 | $308948 |
| **LIABILITIES AND STOCKHOLDERS**' **EQUITY** |  |  |
| Current liabilities: |  |  |
| Trade payables | $1782 | $1125 |
| Deferred revenues | 3052 | 3599 |
| Accrued expenses and other payables | 5239 | 6243 |
| Accrued payroll and related benefits | 13400 | 16964 |
| Operating lease liabilities | 1235 | 2598 |
| Total current liabilities | 24708 | 30529 |
| Long-term liabilities: |  |  |
| Accrued severance pay | 8318 | 7365 |
| Operating lease liabilities | 2543 | 2963 |
| Other accrued liabilities | 1726 | 1535 |
| Total long-term liabilities | 12587 | 11863 |
| Stockholders' equity: |  |  |
| Preferred Stock: $0.001 par value: 5,000,000 shares authorized; none issued and outstanding |  |  |
| Common Stock: $0.001 par value: 45,000,000 shares authorized; 24,133,325 and 23,756,255 shares issued at September 30, 2025 and December 31, 2024, respectively. 24,016,853 and 23,626,865 shares outstanding at September 30, 2025 and December 31, 2024, respectively | 24 | 24 |
| Additional paid in-capital | 269944 | 259891 |
| Treasury stock at cost (116,472 and 129,390 shares of common stock at September 30, 2025, and December 31, 2024, respectively) | (2553) | (3222) |
| Accumulated other comprehensive gain (loss) | 201 | (1330) |
| Retained earnings | 1103 | 11193 |
| Total stockholders' equity | 268719 | 266556 |
| Total liabilities and stockholders' equity | $306014 | $308948 |

---

The accompanying notes are an integral part of the unaudited interim condensed consolidated financial statements.

------

[**Table of Contents**](#toc)

**INTERIM CONDENSED CONSOLIDATED STATEMENTS OF LOSS (UNAUDITED)**

**U.S. dollars in thousands, except per share data**

------

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Nine months ended** | **Nine months ended** | **Three months ended**  | **Three months ended**  |
|  | **September 30,** | **September 30,** | **September 30,** | **September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Revenues: |  |  |  |  |
| Licensing and related revenue | $46092 | $44266 | $16028 | $15574 |
| Royalties | 32215 | 33450 | 12356 | 11633 |
| Total revenues | 78307 | 77716 | 28384 | 27207 |
| Cost of revenues | 10428 | 9397 | 3392 | 3961 |
| Gross profit | 67879 | 68319 | 24992 | 23246 |
| Operating expenses: |  |  |  |  |
| Research and development, net | 55899 | 54739 | 19532 | 17990 |
| Sales and marketing | 9783 | 8999 | 3012 | 3088 |
| General and administrative | 12697 | 11751 | 4383 | 4642 |
| Amortization of intangible assets | 448 | 449 | 149 | 150 |
| Total operating expenses | 78827 | 75938 | 27076 | 25870 |
| Operating loss | (10948) | (7619) | (2084) | (2624) |
| Financial income, net | 5466 | 4962 | 1245 | 2299 |
| Remeasurement of marketable equity securities | (261) | (97) | 1 | 21 |
| Loss before taxes on income | (5743) | (2754) | (838) | (304) |
| Income tax expense | 3797 | 4296 | 1671 | 1007 |
| Net loss | $(9540) | $(7050) | $(2509) | $(1311) |
| Basic and diluted net loss per share | $(0.40) | $(0.30) | $(0.10) | $(0.06) |
| Weighted-average shares used to compute net loss per share (in thousands): |  |  |  |  |
| Basic and diluted | 23869 | 23605 | 23942 | 23678 |

---

The accompanying notes are an integral part of the unaudited interim condensed consolidated financial statements.

------

[**Table of Contents**](#toc)

**INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED)**

**U.S. dollars in thousands**

------

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Nine months ended** | **Nine months ended** | **Three months ended** | **Three months ended** |
|  | **September 30,** | **September 30,** | **September 30,** | **September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Net loss: | $(9540) | $(7050) | $(2509) | $(1311) |
| Other comprehensive income (loss) before tax: |  |  |  |  |
| Available-for-sale securities: |  |  |  |  |
| Changes in unrealized gains | 1497 | 2607 | 483 | 2177 |
| Reclassification adjustments for gains included in net loss | (16) | (14) |  | (4) |
| Net change | 1481 | 2593 | 483 | 2173 |
| Cash flow hedges: |  |  |  |  |
| Changes in unrealized gains (losses) | 1212 | (199) | 66 | 140 |
| Reclassification adjustments for gains included in net loss | (1009) | (767) | (648) | (160) |
| Net change | 203 | (966) | (582) | (20) |
| Other comprehensive income (loss) before tax | 1684 | 1627 | (99) | 2153 |
| Income tax expense related to components of other comprehensive income (loss) | 153 | 254 | 44 | 215 |
| Other comprehensive income (loss), net of taxes | 1531 | 1373 | (143) | 1938 |
| Comprehensive income (loss) | $(8009) | $(5677) | $(2652) | $627 |

---

The accompanying notes are an integral part of the unaudited interim condensed consolidated financial statements.

------

[**Table of Contents**](#toc)

**INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS**' **EQUITY (UNAUDITED)**

**U.S. dollars in thousands, except share data**

------

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Common stock** | **Common stock** |  |  |  |  |  |  |
| **Nine months ended September 30, 2025** | **Number of** <br> **shares** <br> **outstanding** | **Amount** |  | **Additional<br> paid-in<br> capital**  | **Treasury** <br> **stock** | **Accumulated** <br> **other** <br> **comprehensive income (loss)**  | **Retained<br> earnings**  | **Total<br> stockholders'<br> equity**  |
| Balance as of January 1, 2025 | 23626865 | $24 |  | $259891 | $(3222) | $(1330) | $11193 | $266556 |
| Net loss |  |  |  |  |  |  | (9540) | (9540) |
| Other comprehensive income, net |  |  |  |  |  | 1531 |  | 1531 |
| Equity-based compensation |  |  |  | 14098 |  |  |  | 14098 |
| Purchase of treasury stock | (340295) |  | (\*) |  | (7150) |  |  | (7150) |
| Issuance of common stock upon exercise of stock-based awards | 377070 |  | (\*) | 1358 |  |  |  | 1358 |
| Issuance of treasury stock upon exercise of stock-based awards | 353213 |  | (\*) | (5403) | 7819 |  | (550) | 1866 |
| Balance as of September 30, 2025 | 24016853 | $24 |  | $269944 | $(2553) | $201 | $1103 | $268719 |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Common stock** | **Common stock** |  |  |  |  |  |  |
| **Three months ended September 30, 2025** | **Number of** <br> **shares** <br> **outstanding** | **Amount** |  | **Additional<br> paid-in<br> capital**  | **Treasury** <br> **stock** | **Accumulated** <br> **other** <br> **comprehensive income (loss)**  | **Retained<br> earnings**  | **Total<br> stockholders'<br> equity**  |
| Balance as of July 1, 2025 | 23847325 | $24 |  | $267743 | $(5874) | $344 | $3655 | $265892 |
| Net loss |  |  |  |  |  |  | (2509) | (2509) |
| Other comprehensive loss, net |  |  |  |  |  | (143) |  | (143) |
| Equity-based compensation |  |  |  | 4873 |  |  |  | 4873 |
| Purchase of treasury stock | (40295) |  | (\*) |  | (988) |  |  | (988) |
| Issuance of treasury stock upon exercise of stock-based awards | 209823 |  | (\*) | (2672) | 4309 |  | (43) | 1594 |
| Balance as of September 30, 2025 | 24016853 | $24 |  | $269944 | $(2553) | $201 | $1103 | $268719 |

---

------

[**Table of Contents**](#toc)

**INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS**' **EQUITY (UNAUDITED)**

**U.S. dollars in thousands, except share data**

------

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Common stock** | **Common stock** |  |  |  |  |  |  |
| **Nine months ended September 30, 2024** | **Number of** <br> **shares** <br> **outstanding** | **Amount** |  | **Additional<br> paid-in<br> capital**  | **Treasury** <br> **stock** | **Accumulated** <br> **other** <br> **comprehensive income (loss)**  | **Retained<br> earnings**  | **Total<br> stockholders'<br> equity**  |
| Balance as of January 1, 2024 | 23440848 | $23 |  | $252100 | $(5620) | $(2329) | $20167 | $264341 |
| Net loss |  |  |  |  |  |  | (7050) | (7050) |
| Other comprehensive income, net |  |  |  |  |  | 1373 |  | 1373 |
| Equity-based compensation |  |  |  | 11679 |  |  |  | 11679 |
| Purchase of treasury stock | (343604) |  | (\*) |  | (7456) |  |  | (7456) |
| Issuance of common stock upon exercise of stock-based awards | 61065 |  | (\*) |  |  |  |  |  |
| Issuance of treasury stock upon exercise of stock-based awards | 468438 | 1 |  | (7094) | 10133 |  | (157) | 2883 |
| Balance as of September 30, 2024 | 23626747 | $24 |  | $256685 | $(2943) | $(956) | $12960 | $265770 |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Common stock** | **Common stock** |  |  |  |  |  |  |
| **Three months ended September 30, 2024** | **Number of** <br> **shares** <br> **outstanding** | **Amount** |  | **Additional<br> paid-in<br> capital**  | **Treasury** <br> **stock** | **Accumulated** <br> **other** <br> **comprehensive income (loss)**  | **Retained<br> earnings**  | **Total<br> stockholders'<br> equity**  |
| Balance as of July 1, 2024 | 23659925 | $24 |  | $254302 | $(1917) | $(2894) | $14271 | $263786 |
| Net loss |  |  |  |  |  |  | (1311) | (1311) |
| Other comprehensive income, net |  |  |  |  |  | 1938 |  | 1938 |
| Equity-based compensation |  |  |  | 4208 |  |  |  | 4208 |
| Purchase of treasury stock | (186301) |  | (\*) |  | (4180) |  |  | (4180) |
| Issuance of treasury stock upon exercise of stock-based awards | 153123 |  | (\*) | (1825) | 3154 |  |  | 1329 |
| Balance as of September 30, 2024 | 23626747 | $24 |  | $256685 | $(2943) | $(956) | $12960 | $265770 |

---

---

| | |
|:---|:---|
| (\*) | Amount less than $1. |

---

The accompanying notes are an integral part of the consolidated financial statements.

------

[**Table of Contents**](#toc)

**INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)**

**U.S. dollars in thousands**

------

---

| | | |
|:---|:---|:---|
|  | **Nine months ended<br> September 30,** | **Nine months ended<br> September 30,** |
|  | **2025** | **2024** |
| **Cash flows from operating activities:** |  |  |
| Net loss | $(9540) | $(7050) |
| Adjustments required to reconcile net loss to net cash used in operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Depreciation | 2495 | 2155 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Amortization of intangible assets | 625 | 835 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Equity-based compensation | 14098 | 11679 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Realized gain on sale of available-for-sale marketable securities | (16) | (14) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accretion of discount on available-for-sale marketable securities | (635) | (654) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Unrealized foreign exchange gain | (1123) | (467) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Remeasurement of marketable equity securities | 261 | 97 |
| Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Trade receivables, net | (12224) | (7812) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prepaid expenses and other assets | (477) | (3711) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Operating lease right-of-use assets | 1849 | 1353 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accrued interest on bank deposits | 8 | 550 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Deferred tax, net | (99) | (330) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Trade payables | 442 | 422 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Deferred revenues | (547) | 400 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accrued expenses and other payables | (920) | (15) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accrued payroll and related benefits | (4220) | (703) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Operating lease liability | (2121) | (1314) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accrued severance pay, net | 64 | 8 |
| Net cash used in operating activities | (12080) | (4571) |
| **Cash flows from investing activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchase of property and equipment | (1428) | (1926) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Proceeds from the sale of Intrinsix | 3470 | 540 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Asset acquisition |  | (753) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Investment in bank deposits | (2705) | (2000) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Proceeds from bank deposits | 2000 | 10000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Investment in available-for-sale marketable securities | (49843) | (41308) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Proceeds from maturity of available-for-sale marketable securities | 59197 | 24580 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Proceeds from sale of available-for-sale marketable securities | 3914 | 9806 |
| Net cash provided by (used in) investing activities | 14605 | (1061) |
| **Cash flows from financing activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchase of treasury stock | (7150) | (7456) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Proceeds from exercise of stock-based awards | 3224 | 2883 |
| Net cash used in financing activities | (3926) | (4573) |
| Effect of exchange rate changes on cash and cash equivalents | 173 | 146 |
| Decrease in cash and cash equivalents | (1228) | (10059) |
| Cash and cash equivalents at the beginning of the period | 18498 | 23287 |
| Cash and cash equivalents at the end of the period | $17270 | $13228 |
| **Supplemental information of cash-flow activities:** |  |  |
| Cash paid during the period for: |  |  |
| &nbsp;&nbsp;&nbsp; Income and withholding taxes | $1900 | $3934 |
| Non-cash transactions: |  |  |
| &nbsp;&nbsp;&nbsp; Property and equipment purchases incurred but unpaid at period end | $198 | $351 |
| &nbsp;&nbsp;&nbsp; Right-of-use assets obtained in the exchange for operating lease liabilities | $94 | $457 |

---

The accompanying notes are an integral part of the unaudited interim condensed consolidated financial statements.

------

[**Table of Contents**](#toc)

**<u>NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</u>**

**(in thousands, except share data)**

---

| | |
|:---|:---|
| **NOTE 1:** | **BUSINESS**  |

---

The financial information in this quarterly report includes the results of Ceva, Inc. and its subsidiaries (the "Company" or "Ceva").

Ceva is the leader in silicon and software IP enabling Physical AI – the artificial intelligence embedded in billions of devices that connect, sense and infer data in the real world. Ceva views Physical AI as the natural evolution of Edge AI. While Edge AI refers to running AI workloads locally on devices rather than in the cloud, Physical AI extends this concept further: it unifies connectivity, sensing and inference layers into a single fabric that allows devices not only to process data at the edge, but also to interact intelligently with their physical environment and the cloud. Ceva is uniquely positioned as the only company with leadership in innovative silicon and software IP solutions across all three layers. Ceva's technologies power the connectivity, perception and intelligence in today's most advanced smart edge products across consumer IoT, automotive, industrial and infrastructure, and mobile and PC markets.

Ceva is a trusted partner to many of the leading semiconductor and original equipment manufacturer ("OEM") companies servicing not only Ceva's largest target growth markets but also a wide variety of other applications, including smart-home, surveillance, robotics and medical. Ceva's customers incorporate Ceva's IP into application-specific integrated circuits and application-specific standard products that they manufacture, market and sell.

Ceva's portfolio includes:

● Connectivity: Bluetooth, Wi-Fi, Ultra-Wideband, cellular IoT, and 5G-Advanced IP platforms that form the backbone of secure, high-performance communication.

● Sensing: Sensor fusion processors, RealSpace spatial audio, MotionEngine software, and general-purpose digital signal processors ("DSPs") that transform raw sensor data into actionable intelligence.

● Inference: The NeuPro family of NPUs – from NeuPro-Nano for embedded AI to NeuPro-M for generative AI – supported by a unified toolchain for simple model deployment and the SensPro family of AI DSPs for high-performance signal and AI workloads.

Ceva licenses its portfolio of wireless communications and scalable AI IP to its customers, lowering barriers to entry and enabling them to bring new products to market faster, more reliably, efficiently and economically.

---

| | |
|:---|:---|
| **NOTE 2:**  | **BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES** |

---

***Basis of Presentation***

The interim condensed consolidated financial statements have been prepared according to U.S. Generally Accepted Accounting Principles ("U.S. GAAP").

The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2025, are not necessarily indicative of the results that may be expected for the year ending December 31, 2025. For further information, reference is made to the consolidated financial statements and footnotes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024.

The significant accounting policies applied in the annual consolidated financial statements of the Company as of December 31, 2024, contained in the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 27, 2025, have been applied consistently in these unaudited interim condensed consolidated financial statements.

------

[**Table of Contents**](#toc)

**<u>NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)</u>**

**(in thousands, except share data)**

***Concentration of credit risk:***

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash, cash equivalents, bank deposits, marketable securities, foreign exchange contracts and trade receivables. The Company invests its surplus cash in cash deposits and marketable securities in financial institutions and has established guidelines relating to diversification and maturities to maintain safety and liquidity of the investments.

The majority of the Company's cash and cash equivalents are invested in high grade certificates of deposits with major U.S., European and Israeli banks. Generally, cash and cash equivalents and bank deposits may be redeemed on demand and therefore minimal credit risk exists with respect to them. Nonetheless, deposits with these banks exceed the Federal Deposit Insurance Corporation ("FDIC") insurance limits or similar limits in foreign jurisdictions, to the extent such deposits are even insured in such foreign jurisdictions. Generally, these cash equivalents may be redeemed upon demand, and therefore management believes that they bear a lower risk. The short-term bank deposits are held in financial institutions that management believes are institutions with high credit standing and, accordingly, minimal credit risk from geographic or credit concentration. Furthermore, the Company holds an investment portfolio consisting principally of corporate bonds. For available-for-sale debt securities with unrealized loss positions, the Company does not intend to sell these securities and it is more likely than not that the Company will hold these securities until maturity or a recovery of the cost basis. No material credit losses for available-for-sale debt securities were recorded during the periods presented.

The Company's trade receivables are geographically diverse, mainly in the Asia Pacific region, and also in the United States and Europe. Concentration of credit risk with respect to trade receivables is limited by credit limits, ongoing credit evaluation and account monitoring procedures. The Company performs ongoing credit evaluations of its customers. The Company makes estimates of expected credit losses based upon its assessment of various factors, including historical experience, the age of the trade receivable balances, credit quality of its customers, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect its ability to collect from customers.

As of September 30, 2025, the allowance for credit losses amounted to $2,626.

The Company has no off-balance-sheet concentration of credit risk.

***Accounting Standards Recently Issued, Not Yet Adopted by the Company***

In December 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures ("ASU 2023-09"), which requires public entities, on an annual basis, to provide disclosure of specific categories in the rate reconciliation, as well as disclosure of income taxes paid disaggregated by jurisdiction. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2023-09.

In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosure (Subtopic 220-40), Disaggregation of Income Statement Expenses, which requires disclosure of disaggregated information about certain expense captions presented in the Consolidated Statements of Operations as well as disclosure about selling expense. The guidance will be effective for the Company for annual periods beginning January 1, 2027 and interim periods beginning January 1, 2028, with early adoption permitted. It could be applied either prospectively or retrospectively. The Company is currently evaluating the impact on its financial statement disclosures.

In July 2025, the FASB issued ASU 2025-05, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets ("ASU 2025-05"). This amendment introduces a practical expedient for the application of the current expected credit loss model to current accounts receivable and contract assets. ASU 2025-05 is effective for fiscal years beginning after December 15, 2025, and interim reporting periods within those annual reporting periods. Early adoption is permitted. The Company is currently evaluating the timing of adoption and impact of this amendment on its consolidated financial statements and related disclosures.

In September 2025, the FASB issued ASU No. 2025-06, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software. The ASU simplifies the capitalization guidance by removing all references to prescriptive and sequential software development stages (referred to as "project stages") throughout ASC 350-40. The ASU is effective for annual periods beginning after December 15, 2027, and interim periods within those fiscal years. Adoption of this ASU can be applied prospectively for reporting periods after its effective date; or follow a modified transition approach. The Company is currently evaluating the impact of this amendment on its consolidated financial statements and related disclosures.

***Use of Estimates***

The preparation of the interim condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company's management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

------

[**Table of Contents**](#toc)

**<u>NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)</u>**

**(in thousands, except share data)**

---

| | |
|:---|:---|
| **NOTE 3:**  | **ACQUISITION** |

---

In January 2024, the Company acquired a privately held, Greece-based radio frequency design company (now operating under the name "*Ceva Technologies Single Member Private Company*"*)*. Under the terms of the purchase agreement, the Company agreed to pay an aggregate of approximately $753 paid at closing and approximately $2,100 contingent on continued employment and certain performance milestones. During the first quarter of 2025, the Company paid $425 toward this contingent amount. The Company has accounted for the acquisition as an asset acquisition. As such, the total purchase consideration was allocated to the assets acquired.

---

| | |
|:---|:---|
| **NOTE 4:**  | **SALE OF INTRINSIX CORP.** |

---

On September 14, 2023, the Company and Intrinsix Corp. ("Intrinsix") , then its wholly owned subsidiary, entered into a Share Purchase Agreement (the "Agreement") with Cadence Design Systems, Inc. ("Cadence"), pursuant to which Cadence agreed to purchase all of the issued and outstanding capital shares of Intrinsix from the Company for $35,000 in cash, subject to other certain purchase price adjustments as provided for in the Agreement (the "Transaction"). The closing of the Transaction occurred on October 2, 2023. At the closing, an amount of approximately $3,500 of the consideration was deposited with an escrow agent for a period of 18 months as security for the Company's indemnification obligations to Cadence in accordance with the terms and conditions set forth in the Agreement. During the second quarter of 2025, an amount of $3,470 was released from escrow and paid to the Company.

---

| | |
|:---|:---|
| **NOTE 5:**  | **REVENUE RECOGNITION** |

---

Under Accounting Standards Codification ("ASC") No. 606, "Revenue from Contracts with Customers" ("ASC 606"), the Company recognizes revenue when or as it satisfies a performance obligation by transferring intellectual property ("IP") licenses or services to the customer, either at a point in time or over time. The Company recognizes most of its revenues at a point in time upon delivery when the customer accepts control of the IP. The Company recognizes revenue over time on license customization and implementation services by using cost inputs to measure progress toward completion of its performance obligations. The Company considers the post-contract support services as a distinct performance obligation that is satisfied over time, and as such, revenue is recognized ratably over the service period.

Revenues that are derived from the sale of a licensee's products that incorporate the Company's IP are classified as royalty revenues. Royalty revenues are recognized during the quarter in which the sale of the product incorporating the Company's IP occurs. Royalties are calculated either as a percentage of the revenues received by the Company's licensees on sales of products incorporating the Company's IP or on a per unit basis, as specified in the agreements with the licensees. When the Company does not receive actual sales data from the customer prior to the finalization of its financial statements, royalty revenues are recognized based on the Company's estimation of the customer's sales during the quarter. This estimation process for the royalty revenue accrual is based on inputs and estimations received from the Company's customers, as well as sales trends and various market factors. Adjustments to royalty revenues are made in subsequent periods to reflect updated estimates as soon as the final royalty reports are sent to the Company.

The following table includes estimated revenue expected to be recognized in future periods related to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period. The estimated revenues do not include amounts of royalties or unexercised contract renewals:

---

| | | | |
|:---|:---|:---|:---|
|  | **Remainder of**<br> **2025** | **2026** | **2027 and** <br> **thereafter** |
| Licensing and related revenues | $4673 | $6205 | $1351 |

---

------

[**Table of Contents**](#toc)

**<u>NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)</u>**

**(in thousands, except share data)**

<u>Disaggregation of revenue:</u>

The following table provides information about disaggregated revenue by primary geographical, use cases for the Company's technology portfolio, and timing of revenue recognition:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Nine months ended September 30, 2025**<br> **(unaudited)** | **Nine months ended September 30, 2025**<br> **(unaudited)** | **Nine months ended September 30, 2025**<br> **(unaudited)** | **Three months ended September 30, 2025**<br> **(unaudited)** | **Three months ended September 30, 2025**<br> **(unaudited)** | **Three months ended September 30, 2025**<br> **(unaudited)** |
|  | **Licensing** <br> **and**<br> **related**<br> **revenues** | **Royalties**  | **Total** | **Licensing** <br> **and**<br> **related** <br> **revenues** | **Royalties**  | **Total** |
| Geography |  |  |  |  |  |  |
| United States | $11991 | $3952 | $15943 | $5301 | $1479 | $6780 |
| Europe and Middle East | 2553 | 2465 | 5018 | 837 | 687 | 1524 |
| Asia Pacific | 31548 | 25798 | 57346 | 9890 | 10190 | 20080 |
| Total | $46092 | $32215 | $78307 | $16028 | $12356 | $28384 |
| Use cases for the Company's technology portfolio |  |  |  |  |  |  |
| Connect (baseband for handset and other devices, Bluetooth, Wi-Fi and NB-IoT) | $30989 | $24628 | $55617 | $9477 | $9418 | $18895 |
| Sense & Infer (sensor fusion, audio, sound, imaging, vision and AI) | 15103 | 7587 | 22690 | 6551 | 2938 | 9489 |
| Total | $46092 | $32215 | $78307 | $16028 | $12356 | $28384 |
| Timing of revenue recognition |  |  |  |  |  |  |
| Products transferred at a point in time | $35301 | $32215 | $67516 | $13154 | $12356 | $25510 |
| Products and services transferred over time | 10791 |  | 10791 | 2874 |  | 2874 |
| Total | $46092 | $32215 | $78307 | $16028 | $12356 | $28384 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Nine months ended September 30, 2024**<br> **(unaudited)** | **Nine months ended September 30, 2024**<br> **(unaudited)** | **Nine months ended September 30, 2024**<br> **(unaudited)** | **Three months ended September 30, 2024**<br> **(unaudited)** | **Three months ended September 30, 2024**<br> **(unaudited)** | **Three months ended September 30, 2024**<br> **(unaudited)** |
|  | **Licensing**<br> **and** <br> **related** <br> **revenues** | **Royalties**  | **Total** | **Licensing**<br> **and** <br> **related**<br> **revenues** | **Royalties**  | **Total** |
| Geography |  |  |  |  |  |  |
| United States | $7985 | $4037 | $12022 | $7174 | $945 | $8119 |
| Europe and Middle East | 8318 | 3326 | 11644 | 1473 | 1217 | 2690 |
| Asia Pacific | 27950 | 26087 | 54037 | 6927 | 9471 | 16398 |
| Other | 13 |  | 13 |  |  |  |
| Total | $44266 | $33450 | $77716 | $15574 | $11633 | $27207 |
| Use cases for the Company's technology portfolio |  |  |  |  |  |  |
| Connect (baseband for handset and other devices, Bluetooth, Wi-Fi and NB-IoT) | $39283 | $25533 | $64816 | $12960 | $8801 | $21761 |
| Sense & Infer (sensor fusion, audio, sound, imaging, vision and AI) | 4983 | 7917 | 12900 | 2614 | 2832 | 5446 |
| Total | $44266 | $33450 | $77716 | $15574 | $11633 | $27207 |
| Timing of revenue recognition |  |  |  |  |  |  |
| Products transferred at a point in time | $38154 | $33450 | $71604 | $13431 | $11633 | $25064 |
| Products and services transferred over time | 6112 |  | 6112 | 2143 |  | 2143 |
| Total | $44266 | $33450 | $77716 | $15574 | $11633 | $27207 |

---

------

[**Table of Contents**](#toc)

**<u>NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)</u>**

**(in thousands, except share data)**

<u>Contract balances:</u>

The following table provides information about trade receivables, unbilled receivables and contract liabilities from contracts with customers:

---

| | | |
|:---|:---|:---|
|  | **September 30,** <br> **2025** | **December 31,** <br> **2024**  |
| **Currents assets (classified under** "**Trade receivables**"**):** |  |  |
| Trade receivables | $14579 | $15969 |
| Unbilled receivables (associated with licensing and related revenue) | 23331 | 8266 |
| Unbilled receivables (associated with royalties) | 11789 | 12974 |
| Total current assets | 49699 | 37209 |
| **Long-term assets (classified under** "**Other long-term assets**"**):** |  |  |
| Unbilled receivables (associated with licensing and related revenue) | 1174 | 2583 |
| **Deferred revenues (short-term contract liabilities)** | 3052 | 3599 |

---

The Company receives payments from customers based upon contractual payment schedules; trade receivables are recorded when the right to consideration becomes unconditional, and an invoice is issued to the customer. Unbilled receivables associated with licensing and other include amounts related to the Company's contractual right to consideration for completed performance objectives not yet invoiced. Unbilled receivables associated with royalties are recorded as the Company recognizes revenues from royalties earned during the quarter, but not yet invoiced, either by actual sales data received from customers, or, when applicable, by the Company's estimation. Contract liabilities (deferred revenue) include payments received in advance of performance under the contract and are realized with the associated revenue recognized under the contract.

During the three and nine months ended September 30, 2025, the Company recognized $646 and $2,748, respectively, that was included in deferred revenues (short-term contract liability) balance at December 31, 2024.

---

| | |
|:---|:---|
| **NOTE 6:**  | **LEASES** |

---

The Company leases substantially all of its office space and vehicles under operating leases. The Company's leases have original lease periods expiring between 2025 and 2034. Many leases include one or more options to renew. The Company does not assume renewals in its determination of the lease term unless the renewals are deemed to be reasonably certain. Lease payments included in the measurement of the lease liability comprise the following: the fixed non-cancelable lease payments, payments for optional renewal periods where it is reasonably certain the renewal period will be exercised, and payments for early termination options unless it is reasonably certain the lease will not be terminated early.

------

[**Table of Contents**](#toc)

**<u>NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)</u>**

**(in thousands, except share data)**

The following is a summary of weighted average remaining lease terms and discount rates for all of the Company's operating leases:

---

| | |
|:---|:---|
|  | **September 30,** <br> **2025**<br> **(Unaudited)** |
| Weighted average remaining lease term (years) | 4.98 |
| Weighted average discount rates | 3.74% |

---

Total operating lease cost and cash payments for operating leases were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Nine months ended<br> September 30,** | **Nine months ended<br> September 30,** | **Three months ended<br> September 30,** | **Three months ended<br> September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
|  | **(unaudited)** | **(unaudited)** | **(unaudited)** | **(unaudited)** |
| Operating lease cost | $2163 | $2053 | $737 | $696 |
| Cash payments for operating leases | 2433 | 2022 | 607 | 713 |

---

Maturities of lease liabilities are as follows:

---

| | |
|:---|:---|
| The remainder of 2025 | $417 |
| 2026 | 1117 |
| 2027 | 850 |
| 2028 | 478 |
| 2029 | 352 |
| 2030 and thereafter | 901 |
| Total undiscounted cash flows | 4115 |
| Less imputed interest | 337 |
| Present value of lease liabilities | $3778 |

---

During March 2025, the Company signed an operating lease agreement for new offices in Israel, resulting in an additional lease commitment of approximately $9,900. As of September 30, 2025, the lease has not yet commenced. The lease is expected to commence during the fourth quarter of 2025, and will remain in effect until December 30, 2035, with an option to extend the lease for an additional period of up to 5 years, subject to the conditions of the lease agreement.

---

| | |
|:---|:---|
| **NOTE 7:**  | **MARKETABLE SECURITIES** |

---

The following is a summary of available-for-sale marketable securities:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **September 30, 2025 (Unaudited)** | **September 30, 2025 (Unaudited)** | **September 30, 2025 (Unaudited)** | **September 30, 2025 (Unaudited)** |
|  | **Amortized<br> cost** | **Gross<br> unrealized<br> gains** | **Gross<br> unrealized<br> losses** | **Fair<br> value** |
| **Available-for-sale - matures within one year:** |  |  |  |  |
| Corporate bonds | $61009 | $226 | $(389) | $60846 |
| **Available-for-sale - matures after one year through three years:** |  |  |  |  |
| Corporate bonds | 70978 | 372 | (215) | 71135 |
| **Total** |  |  |  |  |
|  | $131987 | $598 | $(604) | $131981 |

---

------

[**Table of Contents**](#toc)

**<u>NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)</u>**

**(in thousands, except share data)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **December 31, 2024**  | **December 31, 2024**  | **December 31, 2024**  | **December 31, 2024**  |
|  | **Amortized<br> cost** | **Gross<br> unrealized<br> gains** | **Gross<br> unrealized<br> losses** | **Fair<br> value** |
| **Available-for-sale - matures within one year:** |  |  |  |  |
| Corporate bonds | $61113 | $41 | $(146) | $61008 |
| **Available-for-sale - matures after one year through three years:** |  |  |  |  |
| Corporate bonds | 83491 | 221 | (1603) | 82109 |
| **Total** | $144604 | $262 | $(1749) | $143117 |

---

The following table presents gross unrealized losses and fair values for those investments that were in an unrealized loss position as of September 30, 2025, and December 31, 2024, and the length of time that those investments have been in a continuous loss position:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Less than 12 months** | **Less than 12 months** | **12 months or greater** | **12 months or greater** |
|  | **Fair value** | **Gross** <br> **unrealized**<br> **loss** | **Fair value** | **Gross**<br> **unrealized**<br> **loss** |
| As of September 30, 2025 (unaudited) | $12074 | $(38) | $30366 | $(566) |
| As of December 31, 2024 | $28762 | $(160) | $61996 | $(1589) |

---

As of September 30, 2025, the allowance for credit losses was not material.

The following table presents gross realized gains and losses from sale of available-for-sale marketable securities:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Nine months ended<br> September 30,** | **Nine months ended<br> September 30,** | **Three months ended<br> September 30,** | **Three months ended<br> September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
|  | **(unaudited)** | **(unaudited)** | **(unaudited)** | **(unaudited)** |
| Gross realized gains from sale of available-for-sale marketable securities | $16 | $19 | $— | $4 |
| Gross realized losses from sale of available-for-sale marketable securities | $— | $(5) | $— | $— |

---

---

| | |
|:---|:---|
| **NOTE 8:**  | **FAIR VALUE MEASUREMENT** |

---

FASB ASC No. 820, "Fair Value Measurements and Disclosures" defines fair value, establishes a framework for measuring fair value. Fair value is an exit price, representing the amount that would be received for selling an asset or paid for the transfer of a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value:

---

| | |
|:---|:---|
| Level I | Unadjusted quoted prices in active markets that are accessible on the measurement date for identical, unrestricted assets or liabilities; |
| Level II | Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability; and |
| Level III | Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity). |

---

------

[**Table of Contents**](#toc)

**<u>NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)</u>**

**(in thousands, except share data)**

The Company measures its marketable securities, investments in marketable equity securities and foreign currency derivative contracts at fair value. The carrying amount of cash, cash equivalents, short-term bank deposits, trade receivables, other accounts receivable, trade payables and other accounts payables approximate fair value due to the short-term maturity of these instruments. Investments in marketable equity securities are classified within Level I as the securities are traded in an active market. Marketable securities and foreign currency derivative contracts are classified within Level II as the valuation inputs are based on quoted prices and market observable data of similar instruments.

The table below sets forth the Company's assets and liabilities measured at fair value by level within the fair value hierarchy. Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Description** | **September** <br> **30, 2025**<br> **(unaudited)** | **Level I** <br> **(unaudited)** | **Level II**<br> **(unaudited)** | **Level III**<br> **(unaudited)** |
| Assets: |  |  |  |  |
| Marketable securities: |  |  |  |  |
| Corporate bonds | $131981 | $— | $131981 | $— |
| Foreign exchange contracts | $203 | $— | $203 | $— |
| Investments in marketable equity securities | $51 | $51 | $— | $— |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Description** | **December** <br> **31, 2024** | **Level I**  | **Level II**  | **Level III** |
| Assets: |  |  |  |  |
| Marketable securities: |  |  |  |  |
| Corporate bonds | $143117 | $— | $143117 | $— |
| Investments in marketable equity securities | $312 | $312 | $— | $— |

---

---

| | |
|:---|:---|
| **NOTE 9:**  | **GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER DATA** |

---

The Company operates as one operating segment. Operating segments are defined as components of an enterprise for which separate financial information is regularly evaluated by the Company's chief operating decision maker ("CODM"), which is the Company's chief executive officer, in deciding how to allocate resources and assess performance. The Company's CODM evaluates the Company's financial information and resources and assesses the performance of these resources on a consolidated basis. There is no expense or asset information that are supplemental to those disclosed in these interim condensed consolidated financial statements, that are regularly provided to the CODM. The allocation of resources and assessment of performance of the operating segment is based on consolidated net income as shown in our interim condensed consolidated statements of loss. The CODM considers net income in the annual forecasting process and reviews actual results when making decisions about allocating resources. Since the Company operates as one operating segment, financial segment information, including profit or loss and asset information, can be found in these interim condensed consolidated financial statements.

a. Summary information about geographic areas:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Nine months ended<br> September 30,** | **Nine months ended<br> September 30,** | **Nine months ended<br> September 30,** |  | **Three months ended<br> September 30,** | **Three months ended<br> September 30,** | **Three months ended<br> September 30,** |
|  | **2025**<br> **(unaudited)** |  | **2024**<br> **(unaudited)** |  | **2025**<br> **(unaudited)** |  | **2024**<br> **(unaudited)** |
| Revenues based on customer location: |  |  |  |  |  |  |  |
| United States | $15943 |  | $12022 |  | $6780 |  | $8119 |
| Europe and Middle East | 5018 |  | 11644 |  | 1524 |  | 2690 |
| Asia Pacific (1)(2) | 57346 |  | 54037 |  | 20080 |  | 16398 |
| Other |  |  | 13 |  |  |  |  |
|  | $78307 |  | $77716 |  | $28384 |  | $27207 |
| (1) China | $44590 |  | $39748 |  | $14746 |  | $10723 |
| (2) South Korea | $— | \*) | $— | \*) | $— | \*) | $3033 |

---

\*) Less than 10%<br>

------

[**Table of Contents**](#toc)

**<u>NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)</u>**

**(in thousands, except share data)**

---

| | | |
|:---|:---|:---|
|  | **September 30, 2025**<br> **(unaudited)** | **December 31,** <br> **2024** |
| Long-lived assets by geographic region: |  |  |
| Israel | $4513 | $6788 |
| France | 1770 | 1916 |
| United States | 1312 | 1716 |
| Greece | 1283 | 984 |
| Other | 1092 | 1284 |
|  | $9970 | $12688 |

---

b. Major customer data as a percentage of total revenues:

The following table sets forth the customers that represented 10% or more of the Company's total revenues in each of the periods set forth below:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Nine months ended<br> September 30,** | **Nine months ended<br> September 30,** | **Three months ended<br> September 30,** | **Three months ended<br> September 30,** |
|  | **2025**<br> **(unaudited)** | **2024**<br> **(unaudited)** | **2025**<br> **(unaudited)** | **2024**<br> **(unaudited)** |
| Customer A | 15% | 13% | 11% | 13% |
| Customer B | \*) | \*) | 11% | \*) |
| Customer C | \*) | \*) | 11% | \*) |
| Customer D | \*) | \*) | \*) | 17% |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; \*) Less than 10%<br>

c. Major customer data as a percentage of total trade receivable:

The following table sets forth the customers that represented 10% or more of the Company's total trade receivable in each of the periods set forth below:

---

| | | |
|:---|:---|:---|
|  | **September 30,** <br> **2025**<br> **(unaudited)** | **December**<br> **31, 2024** |
| Customer A | 17% | 24% |
| Customer B | \*) | 12% |

---

\*) Less than 10%<br>

------

[**Table of Contents**](#toc)

**<u>NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)</u>**

**(in thousands, except share data)**

---

| | |
|:---|:---|
| **NOTE 10:**  | **FINANCIAL INCOME, NET** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Nine months ended<br> September 30,** | **Nine months ended<br> September 30,** | **Three months ended<br> September 30,** | **Three months ended<br> September 30,** |
|  | **2025**<br> **(unaudited)** | **2024**<br> **(unaudited)** | **2025**<br> **(unaudited)** | **2024**<br> **(unaudited)** |
| Interest income | $3907 | $3771 | $1336 | $1225 |
| Gain on available-for-sale marketable securities, net | 16 | 14 |  | 4 |
| Amortization of discount on available-for-sale marketable securities, net | 635 | 654 | 175 | 268 |
| Foreign exchange gain (loss), net | 908 | 523 | (266) | 802 |
| Total | $5466 | $4962 | $1245 | $2299 |

---

---

| | |
|:---|:---|
| **NOTE 11:**  | **NET LOSS PER SHARE OF COMMON STOCK** |

---

Basic net income (loss) per share is computed based on the weighted average number of shares of common stock outstanding during each period. Diluted net income (loss) per share is computed based on the weighted average number of shares of common stock outstanding during each period, plus dilutive potential shares of common stock considered outstanding during the period, in accordance with FASB ASC No. 260, "Earnings Per Share."

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Nine months ended<br> September 30,** | **Nine months ended<br> September 30,** | **Three months ended<br> September 30,** | **Three months ended<br> September 30,** |
|  | **2025**<br> **(unaudited)** | **2024**<br> **(unaudited)** | **2025**<br> **(unaudited)** | **2024**<br> **(unaudited)** |
| **Numerator:** |  |  |  |  |
| Net loss | $(9540) | $(7050) | $(2509) | $(1311) |
| **Denominator (in thousands):** |  |  |  |  |
| Basic and diluted weighted average common stock outstanding | 23869 | 23605 | 23942 | 23678 |
| Basic and diluted net loss per share | $(0.40) | $(0.30) | $(0.10) | $(0.06) |

---

The total number of shares related to outstanding equity-based awards was 1,902,594 for both the three and nine months ended September 30, 2025, and in each case was excluded from the calculation of diluted net loss per share. The total number of shares related to outstanding equity-based awards was 1,684,428 for both the three and nine months ended September 30, 2024, and in each case was excluded from the calculation of diluted net loss per share.

---

| | |
|:---|:---|
| **NOTE 12:**  | **COMMON STOCK AND STOCK-BASED COMPENSATION PLANS** |

---

The Company grants stock options and restricted stock units ("RSUs") to employees and non-employee directors of the Company and its subsidiaries under the Company's equity plans and provides the right to purchase common stock pursuant to the Company's 2002 employee stock purchase plan to employees of the Company and its subsidiaries.

------

[**Table of Contents**](#toc)

**<u>NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)</u>**

**(in thousands, except share data)**

The options granted under the Company's stock incentive plans have been granted at the fair market value of the Company's common stock on the grant date. Options granted to employees under stock incentive plans generally vest at a rate of 25% of the shares underlying the option after one year and the remaining shares vest in equal portions over the following 36 months, such that all shares are vested after four years. A summary of the Company's stock option activities and related information for the nine months ended September 30, 2025, are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Number of<br> options**  | **Weighted<br> average** <br> **exercise<br> price** | **Weighted<br> average**<br> **remaining<br> contractual** <br> **term** | **Aggregate<br> intrinsic** <br> **value** |
| Outstanding as of December 31, 2024 | 84025 | $22.45 | 2.7 | $765 |
| Granted |  |  |  |  |
| Exercised | (27000) | 19.43 |  |  |
| Forfeited or expired |  |  |  |  |
| Outstanding as of September 30, 2025 (unaudited) | 57025 | $23.87 | 3.1 | $165 |
| Exercisable as of September 30, 2025 (unaudited) | 40650 | $25.13 | 2.2 | $72 |

---

As of September 30, 2025, there was $174 of unrecognized compensation expense related to unvested stock options. This amount is expected to be recognized over a weighted-average period of 1.6 years.

An RSU award is an agreement to issue shares of the Company's common stock at the time the award or a portion thereof vests. RSUs granted to employees generally vest in three equal annual installments starting on the first anniversary of the grant date. RSUs granted to non-employee directors, which has historically been granted on or about July 1 of each year, will be made following a director's election or re-election to the Board at the Company's annual meeting, and fully vest on the first-year anniversary of the grant date instead of over a two-year period.

On February 10, 2025, the Compensation Committee of the Board (the "Committee") granted 34,612, 15,575, 13,844 and 13,844 RSUs, effective as of February 14, 2025, to each of the Company's Chief Executive Officer ("CEO"), Chief Financial Officer ("CFO"), Chief Operating Officer ("COO") and Chief Commercial Officer ("CCO"), respectively, pursuant to the Company's 2011 Stock Incentive Plan (the "2011 Plan"). The RSU awards vest 33.4% on February 14, 2026, 33.3% on February 14, 2027 and 33.3% on February 14, 2028.

Also, on February 10, 2025, the Committee granted 51,918, 10,383, 9,229 and 9,229 performance-based stock units ("PSUs"), effective as of February 14, 2025, to each of the Company's CEO, CFO, COO and CCO, respectively, pursuant to the 2011 Plan. The performance goals for the PSUs with specified weighting are as follows:

---

| | |
|:---|:---|
| Weighting | Goals |
| 50% (\*) | Vesting of the full 50% of the PSUs occurs if the Company achieves the 2025 license and related revenue target approved by the Board (the "2025 License Revenue Target"). The vesting threshold is achievement of 90% of the 2025 License Revenue Target. If the Company's achievement of the 2025 License Revenue Target is above 90% but less than 99% of the 2025 License Revenue Target, 91% to 99% of the eligible PSUs would be subject to vesting. If the Company's actual result exceeds 100% of the 2025 License Revenue Target, every 1% increase of the 2025 License Revenue Target, up to 110%, would result in an increase of 7% of the eligible PSUs for the Company's CFO, COO and CCO and an increase of 10% of the eligible PSUs for the Company's CEO. |
| 25% | Vesting of the full 25% of the PSUs occurs if the Company achieves positive total shareholder return whereby the return on the Company's stock for 2025 is greater than the S&P Semiconductors Select Industry index (the "S&P index"). The vesting threshold is if the return on the Company's stock for 2025 is at least 90% of the S&P index. If the return on the Company's stock, in comparison to the S&P index, is above 90% but less than 99% of the S&P index, 91% to 99% of the eligible PSUs would be subject to vesting. If the return on the Company's stock exceeds 100% of the S&P index, every 1% increase in comparison to the S&P index, up to 110%, would result in an increase of 7% of the eligible PSUs for the Company's CFO, COO and CCO and an increase of 10% of the eligible PSUs for the Company's CEO. |
| 25% | Vesting of the full 25% of the PSUs occurs if the Company achieves positive total shareholder return whereby the return on the Company's stock for 2025 is greater than the Russell 2000 index (the "Russell index"). The vesting threshold is if the return on the Company's stock for 2025 is at least 90% of the Russell index. If the return on the Company's stock, in comparison to the Russell index, is above 90% but less than 99% of the Russell index, 91% to 99% of the eligible PSUs would be subject to vesting. If the return on the Company's stock exceeds 100% of the Russell index, every 1% increase in comparison to the Russell index, up to 110%, would result in an increase of 7% of the eligible PSUs for the Company's CFO, COO and CCO and an increase of 10% of the eligible PSUs for the Company's CEO. |

---

(\*) As of September 30, 2025, the Company's management estimates that it is probable that the performance condition will be met by year end.

------

[**Table of Contents**](#toc)

**<u>NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)</u>**

**(in thousands, except share data)**

Accordingly, assuming maximum achievement of the performance goals set forth above, PSUs representing an additional 100%, meaning an additional 51,918, would be eligible for vesting of the Company's CEO, and an additional 70%, meaning an additional 7,268, 6,460 and 6,460, would be eligible for vesting for each of the Company's CFO, COO and CCO, respectively.

Subject to achievement of the thresholds the above performance goals for 2025, the PSUs vest 33.4% on February 14, 2026, 33.3% on February 14, 2027, and 33.3% on February 14, 2028.

A summary of the Company's RSU and PSU activities and related information for the nine months ended September 30, 2025, are as follows:

---

| | | |
|:---|:---|:---|
|  | **Number of<br> RSUs and** <br> **PSUs** | **Weighted** <br> **Average Grant-**<br> **Date<br> Fair Value** |
| Unvested as of December 31, 2024 | 1603508 | $21.01 |
| Granted | 908517 | 23.57 |
| Vested | (557163) | 24.42 |
| Forfeited or expired | (109293) | 20.70 |
| Unvested as of September 30, 2025 (unaudited) | 1845569 | $22.55 |

---

As of September 30, 2025, there was $28,043 of unrecognized compensation expense related to unvested RSUs and PSUs. This amount is expected to be recognized over a weighted-average period of 1.6 years.

The following table shows the total equity-based compensation expense included in the interim condensed consolidated statements of loss:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Nine months ended<br> September 30,** | **Nine months ended<br> September 30,** | **Three months ended<br> September 30,** | **Three months ended<br> September 30,** |
|  | **2025**<br> **(unaudited)** | **2024**<br> **(unaudited)** | **2025**<br> **(unaudited)** | **2024**<br> **(unaudited)** |
| Cost of revenue | $493 | $570 | $168 | $176 |
| Research and development, net | 7778 | 6866 | 2639 | 2421 |
| Sales and marketing | 1735 | 1307 | 571 | 491 |
| General and administrative | 4092 | 2936 | 1495 | 1120 |
| Total equity-based compensation expense | $14098 | $11679 | $4873 | $4208 |

---

------

[**Table of Contents**](#toc)

**<u>NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)</u>**

**(in thousands, except share data)**

The fair value for rights to purchase shares of common stock under the Company's employee stock purchase plan was estimated on the date of grant using the following assumptions:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Nine months ended<br> September 30** | **Nine months ended<br> September 30** | **Nine months ended<br> September 30** | **Nine months ended<br> September 30** | **Three months ended<br> September 30** | **Three months ended<br> September 30** |
|  | **2025**<br> **(unaudited)** | **2025**<br> **(unaudited)** | **2024**<br> **(unaudited)** | **2024**<br> **(unaudited)** | **2025**<br> **(unaudited)** | **2024**<br> **(unaudited)** |
| Expected dividend yield | 0% | 0% | 0% | 0% | 0% | 0% |
| Expected volatility | 41% | 70% | 46% | 50% | 70% | 50% |
| Risk-free interest rate | 4.0% | 4.4% | 4.9% | 5.3% | 4.0% | 4.9% |
| Contractual term of up to (months) | 24 | 24 | 24 | 24 | 24 | 24 |

---

---

| | |
|:---|:---|
| **NOTE 13:**  | **TAXES**  |

---

On July 4, 2025, the One Big Beautiful Bill Act ("OBBBA") was signed into law. This legislation includes changes to U.S. federal tax law, which may be subject to further clarification and the issuance of interpretive guidance. The impact of OBBBA for the quarter ended September 30, 2025 did not have a material impact on the Company's financial position for the period. The Company continues to evaluate the impact of OBBBA on its consolidated financial statements and will update its estimates as additional guidance becomes available.

---

| | |
|:---|:---|
| **NOTE 14:**  | **DERIVATIVES AND HEDGING ACTIVITIES**  |

---

The Company follows the requirements of FASB ASC No. 815," Derivatives and Hedging" which requires companies to recognize all of their derivative instruments as either assets or liabilities in the statement of financial position at fair value. The accounting for changes in fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging transaction and further, on the type of hedging transaction. For those derivative instruments that are designated and qualify as hedging instruments, a company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation. Due to the Company's global operations, it is exposed to foreign currency exchange rate fluctuations in the normal course of its business. The Company's treasury policy allows it to offset the risks associated with the effects of certain foreign currency exposures through the purchase of foreign exchange forward or option contracts ("Hedging Contracts"). The policy, however, prohibits the Company from speculating on such Hedging Contracts for profit. To protect against the increase in value of forecasted foreign currency cash flow resulting from salaries paid in currencies other than the U.S. dollar during the year, the Company instituted a foreign currency cash flow hedging program. The Company hedges portions of the anticipated payroll of its non-U.S. employees denominated in the currencies other than the U.S. dollar for a period of one to twelve months with Hedging Contracts. Accordingly, when the dollar strengthens against the foreign currencies, the decline in present value of future foreign currency expenses is offset by losses in the fair value of the Hedging Contracts. Conversely, when the dollar weakens, the increase in the present value of future foreign currency expenses is offset by gains in the fair value of the Hedging Contracts. These Hedging Contracts are designated as cash flow hedges.

For derivative instruments that are designated and qualify as a cash flow hedge (i.e., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk), the gain or loss on the derivative instrument is reported as a component of other comprehensive income (loss) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. As of September 30, 2025, the notional principal amount of the Hedging Contracts to sell U.S. dollars held by the Company was $1,400. There were no open Hedging Contracts as of December 31, 2024.

The fair value of the Company's outstanding derivative instruments is as follows:

---

| | | |
|:---|:---|:---|
|  | **September 30,** <br> **2025**<br> **(unaudited)** | **December 31,** <br> **2024** |
| **Derivative assets:** |  |  |
| Derivatives designated as cash flow hedging instruments: |  |  |
| Foreign exchange forward contracts | $203 | $— |
| Total | $203 | $— |

---

------

[**Table of Contents**](#toc)

**<u>NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)</u>**

**(in thousands, except share data)**

The increase (decrease) in unrealized gains (losses) recognized in "accumulated other comprehensive gain (loss)" on derivatives, before tax effect, is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Nine months ended<br> September 30,** | **Nine months ended<br> September 30,** | **Three months ended<br> September 30,** | **Three months ended<br> September 30,** |
|  | **2025**<br> **(unaudited)** | **2024**<br> **(unaudited)** | **2025**<br> **(unaudited)** | **2024**<br> **(unaudited)** |
| Derivatives designated as cash flow hedging instruments: |  |  |  |  |
| Foreign exchange option contracts | $283 | $41 | $1 | $25 |
| Foreign exchange forward contracts | 929 | (240) | 65 | 115 |
|  | $1212 | $(199) | $66 | $140 |

---

The net gains reclassified from "accumulated other comprehensive gain (loss)" into income are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Nine months ended<br> September 30,** | **Nine months ended<br> September 30,** | **Three months ended<br> September 30,** | **Three months ended<br> September 30,** |
|  | **2025**<br> **(unaudited)** | **2024**<br> **(unaudited)** | **2025**<br> **(unaudited)** | **2024**<br> **(unaudited)** |
| Derivatives designated as cash flow hedging instruments: |  |  |  |  |
| Foreign exchange option contracts | $(283) | $(41) | $(283) | $(16) |
| Foreign exchange forward contracts | (726) | (726) | (365) | (144) |
|  | $(1009) | $(767) | $(648) | $(160) |

---

The Company recorded in cost of revenues and operating expenses a net gain of $648 and $1,009 during the three and nine months ended September 30, 2025, respectively, and a net gain of $160 and $767 during the comparable periods of 2024, related to its Hedging Contracts.

---

| | |
|:---|:---|
| **NOTE 15:**  | **ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)** |

---

The following tables summarize the changes in accumulated balances of other comprehensive income (loss), net of taxes:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Nine months ended September 30, 2025** <br> **(unaudited)** | **Nine months ended September 30, 2025** <br> **(unaudited)** | **Nine months ended September 30, 2025** <br> **(unaudited)** | **Three months ended September 30, 2025** <br> **(unaudited)** | **Three months ended September 30, 2025** <br> **(unaudited)** | **Three months ended September 30, 2025** <br> **(unaudited)** |
|  | **Unrealized**<br> **gains** <br> **(losses)** <br> **on** <br> **available-**<br> **for-sale** <br> **marketable** <br> **securities** | **Unrealized** <br> **gains**<br> **(losses)**<br> **on cash flow**<br> **hedges** | **Total** | **Unrealized**<br> **gains** <br> **(losses)** <br> **on** <br> **available-**<br> **for-sale** <br> **marketable** <br> **securities** | **Unrealized**<br> **gains** <br> **(losses) on** <br> **cash flow** <br> **hedges** | **Total** |
| Beginning balance | $(1330) | $— | $(1330) | $(441) | $785 | $344 |
| Other comprehensive income before reclassifications | 1343 | 1212 | 2555 | 439 | 66 | 505 |
| Amounts reclassified from accumulated other comprehensive loss | (15) | (1009) | (1024) |  | (648) | (648) |
| Net current period other comprehensive income (loss) | 1328 | 203 | 1531 | 439 | (582) | (143) |
| Ending balance | $(2) | $203 | $201 | $(2) | $203 | $201 |

---

------

[**Table of Contents**](#toc)

**<u>NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)</u>**

**(in thousands, except share data)**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Nine months ended September 30, 2024**<br> **(unaudited)** | **Nine months ended September 30, 2024**<br> **(unaudited)** | **Nine months ended September 30, 2024**<br> **(unaudited)** | **Three months ended September 30, 2024**<br> **(unaudited)** | **Three months ended September 30, 2024**<br> **(unaudited)** | **Three months ended September 30, 2024**<br> **(unaudited)** |
|  | **Unrealized**<br> **gains** <br> **(losses)** <br> **on** <br> **available-**<br> **for-sale** <br> **marketable** <br> **securities** | **Unrealized** <br> **gains**<br> **(losses)**<br> **on cash flow**<br> **hedges** | **Total** | **Unrealized**<br> **gains** <br> **(losses)**<br> **on** <br> **available-**<br> **for-sale** <br> **marketable** <br> **securities** | **Unrealized** <br> **gains** <br> **(losses)**<br> **on cash flow**<br> **hedges** | **Total** |
| Beginning balance | $(3317) | $988 | $(2329) | $(2936) | $42 | $(2894) |
| Other comprehensive income (loss) before reclassifications | 2353 | (200) | 2153 | 1962 | 140 | 2102 |
| Amounts reclassified from accumulated other comprehensive loss | (14) | (766) | (780) | (4) | (160) | (164) |
| Net current period other comprehensive income (loss) | 2339 | (966) | 1373 | 1958 | (20) | 1938 |
| Ending balance | $(978) | $22 | $(956) | $(978) | $22 | $(956) |

---

------

[**Table of Contents**](#toc)

**<u>NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS- CONTINUED (UNAUDITED)</u>**

**(in thousands, except share data)**

The following table provides details about reclassifications out of accumulated other comprehensive income (loss):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Details about Accumulated** <br> **Other Comprehensive Income** <br> **(Loss) Components** | **Amount Reclassified from Accumulated Other**<br> **Comprehensive Income (Loss)** | **Amount Reclassified from Accumulated Other**<br> **Comprehensive Income (Loss)** | **Amount Reclassified from Accumulated Other**<br> **Comprehensive Income (Loss)** | **Amount Reclassified from Accumulated Other**<br> **Comprehensive Income (Loss)** | **Affected Line Item in the** <br> **Statements of Income (Loss)** |
|  | **Nine months ended** <br> **September 30,** | **Nine months ended** <br> **September 30,** | **Three months ended** <br> **September 30,** | **Three months ended** <br> **September 30,** |  |
|  | **2025<br> (unaudited)** | **2024<br> (unaudited)** | **2025<br> (unaudited)** | **2024<br> (unaudited)** |  |
| Unrealized gains on cash flow hedges | $29 | $17 | $18 | $4 | Cost of revenues |
|  | 833 | 653 | 536 | 135 | Research and development |
|  | 39 | 19 | 25 | 4 | Sales and marketing |
|  | 108 | 78 | 69 | 17 | General and administrative |
|  | 1009 | 767 | 648 | 160 | Total, before income taxes |
|  |  | 1 |  |  | Income tax expense |
|  | 1009 | 766 | 648 | 160 | Total, net of income taxes |
| Unrealized gains on available-for-sale marketable securities | 16 | 14 |  | 4 | Financial income, net |
|  | 1 |  |  |  | Income tax expense |
|  | 15 | 14 |  | 4 | Total, net of income taxes |
|  | $1024 | $780 | $648 | $164 | Total, net of income taxes |

---

---

| | |
|:---|:---|
| **NOTE 16:**  | **SHARE REPURCHASE PROGRAM**  |

---

During the three months ended September 30, 2025, the Company repurchased 40,295 shares of common stock at an average purchase price of $24.53 per share for an aggregate purchase price of $988. During the nine months ended September 30, 2025, the Company repurchased 340,295 shares of common stock at an average purchase price of $21.01 per share for an aggregate purchase price of $7,150. During the three months ended September 30, 2024, the Company repurchased 186,301 shares of common stock at an average purchase price of $22.44 per share for an aggregate purchase price of $4,180. During the nine months ended September 30, 2024, the Company repurchased 343,604 shares of common stock at an average purchase price of $21.70 per share for an aggregate purchase price of $7,456. As of September 30, 2025, 684,486 shares of common stock remained available for repurchase pursuant to the Company's share repurchase program.

The repurchases of common stock are accounted for as treasury stock, and result in a reduction of stockholders' equity. When treasury shares are reissued, the Company accounts for the reissuance in accordance with FASB ASC No. 505-30, "Treasury Stock" and charges the excess of the repurchase cost over issuance price using the weighted average method to retained earnings. The purchase cost is calculated based on the specific identification method. In the case where the repurchase cost over issuance price using the weighted average method is lower than the issuance price, the Company credits the difference to additional paid-in capital.

---

| | |
|:---|:---|
| **NOTE 17:**  | **SUBSEQUENT EVENTS** |

---

In February, August and November 2023, the Committee approved of the grant of an aggregate of 199,318 PSUs (the "Long-Term PSUs") to the Company's executive officers and certain other senior employees, pursuant to the 2011 Plan, except with respect to Amir Panush, the Company's chief executive officer, who received an inducement award on substantially the same terms. The Long-Term PSUs provided for vesting upon the first achievement of specified performance goals during the three-year period from January 1, 2023 through December 31, 2025. On November 9, 2025, the Committee determined to amend the Long-Term PSUs to extend the performance period to December 31, 2027. The Committee determined to approve the extension, in lieu of allowing the Long-Term PSUs to potentially expire unvested, based on its belief that the achievement of the Long-Term PSU goals during the extended period would still reflect significant improvements in operating performance and that the extension would therefore align executive incentives with long-term value for the Company and its stockholders.

------

[**Table of Contents**](#toc)

---

| | |
|:---|:---|
| **Item 2.** | **MANAGEMENT**'**S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS** |

---

*You should read the following discussion together with the unaudited financial statements and related notes appearing elsewhere in this quarterly report. This discussion contains forward-looking statements that involve risks and uncertainties. Any or all of our forward-looking statements in this quarterly report may turn out to be wrong. These forward-looking statements can be affected by inaccurate assumptions we might make or by known or unknown risks and uncertainties. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Factors which could cause actual results to differ materially include those set forth under in Part II* – *Item 1A* – "*Risk Factors,*" *as well as those discussed elsewhere in this quarterly report. See* "*Forward-Looking Statements.*"

*The financial information presented in this quarterly report includes the results of Ceva, Inc. and its subsidiaries.* 

**BUSINESS OVERVIEW**

We enable Physical AI, the artificial intelligence embedded in billions of devices that connect, sense and infer data in the real world. We view Physical AI as the natural evolution of Edge AI. While Edge AI refers to running AI workloads locally on devices rather than in the cloud, Physical AI extends this concept further: it unifies connectivity, sensing and inference layers into a single fabric that allows devices not only to process data at the edge, but also to interact intelligently with their physical environment and the cloud. Ceva is uniquely positioned as the only company with leadership in innovative silicon and software IP solutions across all three layers.

According to IPnest, we commanded 68% of the wireless connectivity IP market in 2024. Since 2003, more than 20 billion devices have shipped with Ceva IP, including approximately 2 billion in 2024 alone. Our technologies power the connectivity, perception and intelligence in today's most advanced smart edge products across consumer IoT, automotive, industrial and infrastructure, and mobile and PC markets. Based on market research, we believe these sectors will represent a $170 billion total addressable market for Physical AI and Edge AI by 2030.

Our portfolio spans:

● **Connectivity layer** (wireless transport): Bluetooth, Wi-Fi, Ultra-Wideband (UWB), cellular internet-of-things (IoT), and 5G-Advanced IP platforms that form the backbone of ubiquitous, secure, and high-performance communication.

● **Sensing layer** (software and DSPs): Sensor fusion processors, RealSpace spatial audio, MotionEngine software, and general-purpose digital signal processors (DSPs) that transform raw sensor data into actionable intelligence.

● **Inference layer** (NPUs and AI DSPs): The NeuPro family of neural processing units (NPUs), from NeuPro-Nano for embedded AI to NeuPro-M for generative AI, supported by a unified toolchain and software stack for simple model deployment, and the SensPro family of AI DSPs for high-performance signal and AI workloads.

Together, these layers make Ceva, with our unified AI fabric, an essential enabler of Physical AI that breaks down barriers to entry and accelerates time-to-market for our customers.

For more than three decades, we have been a trusted partner to hundreds of leading semiconductor and original equipment manufacturer (OEM) companies, serving not only our largest target growth markets but also a wide variety of other applications, including smart home, surveillance, robotics and medical. Our transformative semiconductor IP and embedded software offerings are incorporated by customers into application-specific integrated circuits (ASICs) and application-specific standard products (ASSPs) to enable power-efficient, intelligent, secure and connected devices that connect, sense and infer – the three critical pillars of the rapidly evolving era of AI-enabled smart edge technology.

We license our portfolio of wireless communications and scalable Edge AI IP to our customers, breaking down barriers to entry and enabling them to bring new cutting-edge products to market faster, more reliably, efficiently and economically.

We believe our portfolio of technologies comprised of connectivity, sensing and inference – the three foundational layers of Physical AI – positions Ceva at the center of the most important megatrends shaping the semiconductor industry, including 5G expansion, generative and embedded AI, industrial automation and vehicle electrification. Demand across these areas continues to drive strong interest in our IP portfolio, both in established markets and in new, emerging use cases. In the third quarter of 2025, we signed twelve IP licensing agreements that underscore this momentum: a comprehensive deal with Microchip to adopt our full NeuPro NPU portfolio and embed AI across their product families; multiple agreements for our SensPro AI DSPs, including one with a global electronics OEM targeting home appliances and another with an automotive customer developing an ADAS chiplet architecture; and a major connectivity win with a leading customer licensing our Wi-Fi 7 and Bluetooth High Data Throughput IP for their upcoming roadmaps. These agreements not only validate the breadth of our portfolio but also cement multi-year volume and royalty ramps, reinforcing Ceva's role as the enabler of Physical AI across consumer, automotive, industrial and infrastructure markets.

------

[**Table of Contents**](#toc)

We believe the following key elements represent significant growth drivers for Ceva as the leader in silicon and software IP enabling Physical AI, spanning the three foundational layers of connectivity, sensing and inference:

● **Connectivity layer** – **Foundation for billions of devices:** Our broad Bluetooth, Wi-Fi, UWB, and cellular IoT IP platforms address the high-volume IoT, industrial, consumer, and smart home markets. ABI Research projects more than 16.5 billion devices annually by 2029. With leadership in Wi-Fi 6 and Wi-Fi 7 IP, and record Wi-Fi 6 shipments in 2025, we believe we are positioned to capture higher royalty revenues as customers transition to newer standards.

● **Connectivity layer** – **5G everywhere:** Our PentaG2 platform and DSPs for 5G mobile broadband and 5G RedCap provide one of the industry's most comprehensive baseband IP solutions, enabling fixed wireless access, satellite communications, robotics, automotive and industrial applications.

● **Connectivity layer** – **Infrastructure intelligence:** Our PentaG RAN platform, including the Ceva-XC22 multi-thread DSP, extends our leadership into 5G RAN and 5G Advanced for data centers and infrastructure, enabling scalable, customizable solutions for next-generation networks.

● **Sensing layer** – **Consumer audio and spatial intelligence:** High-volume consumer audio markets such as TWS earbuds, AR/VR headsets, and wearables represent incremental growth opportunities for our Bluetooth, Audio AI DSPs, NPUs and RealSpace Spatial Audio & Head Tracking software. Recent design wins with Nothing and other consumer brands highlight growing adoption.

● **Sensing layer** – **Software intelligence at scale:** Our MotionEngine software, already shipped in more than 400 million devices, enhances MEMS-based inertial and environmental sensors across robotics, smartphones, laptops, TWS earbuds, and more. Combined with our SensPro DSPs and NeuPro NPUs, we believe this positions Ceva as a one-stop shop for sensor processing and AI-driven user experiences.

● **Inference layer** – **Generative and classic AI at the edge:** Our NeuPro-M AI NPU family delivers efficient, high-performance architectures for generative and classic AI across devices from gateways and notebooks to AR/VR and smartphones. Recent agreements include Microchip's portfolio license win for our NeuPro-M and NeuPro-Nano family of NPUs.

● **Inference layer** – **AI DSPs for perception and sensor intelligence:** Our SensPro2 AI DSP family addresses demand for efficient, high-performance AI signal processing across sensor-rich applications, from smartphones and drones to automotive ADAS and industrial IoT. Bloomberg Intelligence forecasts $58 billion in computer vision AI hardware and $110 billion in conversational AI hardware revenues by 2032, underscoring the scale of this opportunity. SensPro, as an inference-class AI DSP, extends Ceva's leadership beyond NPUs into versatile, programmable AI compute.

As a result of our focus on silicon and software IP solutions spanning the connectivity, sensing and inference layers of Physical AI, we believe Ceva is well positioned for sustained, long-term growth in both shipments and royalty revenues. Our diversified royalty streams reflect a broad range of advanced semiconductor packages (ASPs) – from high-volume Bluetooth and Wi-Fi connectivity platforms that power billions of consumer devices to higher-value inference engines and AI DSPs such as NeuPro and SensPro, as well as infrastructure-class platforms like PentaG-RAN. We believe this mix provides both scale and resilience, enabling us to capture growth across consumer, automotive, industrial and infrastructure markets while reinforcing our role as the enabler of Physical AI.

**CURRENT TRENDS**

We believe the long-term trend of digital transformation is evolving into a new era defined by Physical AI – the next phase of Edge AI – where intelligence is embedded directly into the devices that connect, sense and interact with the real world. Our ubiquitous IP portfolio and collaborative licensing model position us to capture secular growth across consumer IoT, automotive, industrial and infrastructure, and mobile and PC markets.

------

[**Table of Contents**](#toc)

Our customers are increasingly receptive to our roadmap because it aligns with their need to add connectivity, sensing and intelligence at the edge. In 2024, this strategy returned us to year-over-year revenue growth of 10%, outperforming our initial expectations of 4% to 8%. For 2025, we expected continued expansion of licensing and related revenues driven by demand for intelligent, connected devices, particularly in industrial IoT and consumer IoT devices. The third quarter of 2025 provided further evidence of this trend, with twelve total licensing agreements, including a comprehensive NPU portfolio deal with Microchip, new AI DSP wins in consumer electronics and automotive ADAS, and multi-year connectivity ramps in Wi Fi 7 and Bluetooth.

In addition, we expect to complement our strong presence in the Asia-Pacific region by further expanding our customer base and revenues in Europe and the U.S., as reflected in our increasingly diversified geographic revenue mix from 2022 through 2024. This balance strengthens our resilience and underscores Ceva's role as the leader in silicon and software IP enabling Physical AI across global markets.

However, the global economy continues to be impacted by macroeconomic conditions, including as a volatile interest rate environment, ongoing inflation and recent changes in legislation and regulations, including enacted and proposed tariffs and other trade policies, have introduced additional uncertainty in the global economy. In periods of perceived or actual unfavorable economic conditions, our customers or potential customers could delay or re-evaluate their decisions to initiate various projects which in turn could result in a delay or cessation of engagement or other business activities with us, and which could result in lower licensing revenues. In addition, lower consumer demand may result in lower royalty revenues as our customers ship fewer units. These factors may make it difficult for us to forecast and plan future budgetary decisions or business activities accurately. Accordingly, while we do not currently expect our IP solutions will themselves be subject to tariffs, the indirect impact on consumer demand, among other factors, increased the uncertainty about the year. Given these evolving dynamics, as well as our lower than anticipated revenues for the first quarter, in May 2025, we adopted a more cautious outlook and lowered our revenue guidance for the 2025 fiscal year from around a high-single digits range to a low-single digits range for growth over 2024 annual revenues. We have not changed this guidance to date.

**Instability in the Middle East**

Our operations in Israel remain largely unaffected by the war between Israel and Hamas that began on October 7, 2023 and escalated to conflicts with Lebanon, Hezbollah and Iran. Nevertheless, we continue to drive our business and support our customers globally. However, a portion of our employees in Israel have been or are called to active reserve duty and additional employees may be called in the future, if needed. The Company has executed its business continuity plan with respect to those employees. It is possible that some of our operations in the region may be disrupted if this continues for a significant period of time or if the situation further deteriorates. Currently a cease-fire is in place, resulting in "back to normal" work and life and travel environments. For more information, please refer to the risk factor titled "Our operations in Israel may be adversely affected by instability in the Middle East region" in Part I—Item IA—"Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024.

------

[**Table of Contents**](#toc)

**RESULTS OF OPERATIONS**

*Total Revenues*

Total revenues were $28.4 million and $78.3 million for the third quarter and first nine months of 2025, respectively, representing an increase of 4% and 1% as compared to the corresponding periods in 2024. The increase in total revenues for the third quarter of 2025 was due to higher licensing and related revenues and higher royalty revenues, as further described below. The increase in total revenues for the first nine months of 2025 was due to higher licensing and related revenues, offset by lower royalty revenues, as further described below.

Our five largest customers accounted for 45% and 39% of our total revenues for the third quarter and first nine months of 2025, respectively, as compared to 48% and 44% for the comparable periods in 2024. Three customers each accounted for 11% of our total revenues for the third quarter of 2025, as compared to two customers that accounted for 17% and 13% of our total revenues for the third quarter of 2024. One customer accounted for 15% of our total revenues for the first nine months of 2025, as compared to one customer that accounted for 13% of our total revenues for the first nine months of 2024. Sales to UNISOC (formerly Spreadtrum Communications, Inc. and RDA Corporation) represented 11% and 15% of our total revenues for the third quarter and first nine months of 2025, respectively. Generally, the identity of our customers representing 10% or more of our total revenues varies from period to period, especially with respect to our IP licensing customers as we generate licensing revenues generally from new customers on a quarterly basis. With respect to our royalty revenues, two royalty paying customers represented 10% or more of our total royalty revenues for both the third quarter and first nine months of 2025 and collectively represented 36% and 35% of our total royalty revenues for the third quarter and first nine months of 2025, respectively. Two royalty paying customers represented 10% or more of our total royalty revenues for both the third quarter and first nine months of 2024 and collectively represented 43% of our total royalty revenues for both the third quarter and first nine months of 2024. We expect that a significant portion of our future revenues will continue to be generated by a limited number of customers. The concentration of our customers is explainable in part by consolidation in the semiconductor industry.

The following table sets forth use cases for the Ceva technology portfolio as percentages of our total revenues for each of the periods set forth below:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **First Nine** <br> **Months<br> 2025** | **First Nine** <br> **Months<br> 2024** | **Third** <br> **Quarter<br> 2025** | **Third**<br> **Quarter<br> 2024** |
| Connect (baseband for handset and other devices, Bluetooth, Wi-Fi and NB-IoT) | 71% | 83% | 67% | 80% |
| Sense & Infer (sensor fusion, audio, sound, imaging, vision and AI) | 29% | 17% | 33% | 20% |

---

*Licensing and Related Revenues*

Licensing and related revenues were $16.0 million and $46.1 million for the third quarter and first nine months of 2025, respectively, representing an increase of 3% and 4% as compared to the corresponding periods in 2024. In licensing, we secured several strategic agreements that reinforce our market-leading position in wireless connectivity and accelerate our expansion in AI. The third quarter of 2025 was marked by strong execution across our core pillars – connect, sense and infer – and highlights the breadth and strength of our IP portfolio. The most significant win was in AI, where Microchip, one of the world's leading microcontroller and connectivity providers, adopted our full NeuPro NPU portfolio for its future roadmap. We believe this win represents a strong proof point of a broader industry trend: major microcontroller unit and semiconductor vendors are standardizing to embed AI across their product lines, bringing more on-device intelligence for performance, user experience, privacy and cost. The increase in licensing and related revenues for the first nine months of 2025 was primarily due to the aforementioned increase in revenue coming from our Edge AI technologies, as well as several key deals signed with strategic customers incorporating our new Bluetooth 7 solutions in their long-term roadmaps, partially offset by two strategic deals signed in the second quarter of 2024 with our large OEM customers in wireless infrastructure for their development of next-generation ASICs.

During the quarter, twelve IP licensing agreements were signed, targeting a wide range of end markets and applications, including NPU for AI across industrial, consumer, automotive and other end markets, AI DSP for automotive ADAS and home appliances, communications DSPs for vehicle-2-everything (V2X) and satellite, and Bluetooth and Wi-Fi connectivity for a wide range of consumer, wearables, smart home and industrial smart edge devices. One of the deals signed was with a first-time customer and one was with an OEM customer.

Licensing and related revenues accounted for 56% and 59% of our total revenues for the third quarter and first nine months of 2025, respectively, as compared to 57% for both the comparable periods of 2024.

*Royalty Revenues*

Royalty revenues were $12.4 million and $32.2 million for the third quarter and first nine months of 2025, respectively, representing an increase of 6% and a decrease of 4% as compared to the corresponding periods in 2024. The first nine months of 2025 included revenue of $0.3 million following the resolution of royalty audits. The third quarter and first nine months of 2024 included revenue of $0.3 million and $2.0 million, respectively, following the resolution of royalty audits. Excluding these amounts, the third quarter and first nine months of 2025 would have been up by 9% and 1%, respectively, as compared to the comparable periods of 2024. Royalty revenues accounted for 44% and 41% of our total revenues for the third quarter and first nine months of 2025, respectively, as compared to 43% for both the comparable periods of 2024. We delivered solid growth across most of our markets, with royalties up 6% year-over-year and 16% sequentially. Consumer IoT was a key driver, posting 9% year-over-year growth, supported by record shipments in cellular IoT and Wi-Fi. Our 5G RAN infrastructure customers also had a strong quarter, with revenues up 91% compared to last year. In automotive, ADAS ramps at our two large semiconductor customers continued to accelerate, contributing to overall royalty growth in the quarter. Mobile royalties grew 4% year-over-year and 7% sequentially, driven by a recovering low-end smartphone segment. At the high end, our U.S. OEM customer launched a second smartphone model featuring its in-house 5G modem with Ceva technology, and as this model expands into more markets in the fourth quarter, we expect further royalty growth.

------

[**Table of Contents**](#toc)

The five largest royalty-paying customers accounted for 54% of our total royalty revenues for both the third quarter and first nine months of 2025, as compared to 61% and 60% for the comparable periods of 2024.

*Geographic Revenue Analysis*

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Nine Months<br> 2025** | **Nine Months<br> 2025** | **Nine Months<br> 2024** | **Nine Months<br> 2024** | **Third Quarter<br> 2025** | **Third Quarter<br> 2025** | **Third Quarter<br> 2024** | **Third Quarter<br> 2024** |
|  | **(in millions, except percentages)** | **(in millions, except percentages)** | **(in millions, except percentages)** | **(in millions, except percentages)** | **(in millions, except percentages)** | **(in millions, except percentages)** | **(in millions, except percentages)** | **(in millions, except percentages)** |
| United States | $15.9 | 20% | $12.0 | 15% | $6.8 | 24% | $8.1 | 30% |
| Europe and Middle East | $5.0 | 7% | $11.6 | 15% | $1.5 | 5% | $2.7 | 10% |
| Asia Pacific (1) (2) | $57.3 | 73% | $54.0 | 70% | $20.1 | 71% | $16.4 | 60% |
| (1) China | $44.6 | 57% | $39.7 | 51% | $14.7 | 52% | $10.7 | 39% |
| (2) South Korea | $\*) | \*) | $\*) | \*) | $\*) | \*) | $3.0 | 11% |
| \*) Less than 10% |  |  |  |  |  |  |  |  |

---

Due to the nature of our license agreements and the associated potential large individual contract amounts, the geographic split of revenues both in absolute dollars and percentage terms generally varies from quarter to quarter.

*Cost of Revenues*

Cost of revenues was $3.4 million and $10.4 million for the third quarter and first nine months of 2025, respectively, as compared to $4.0 million and $9.4 million for the comparable periods of 2024. Cost of revenues accounted for 12% and 13% of our total revenues for the third quarter and first nine months of 2025, respectively, as compared to 15% and 12% for the comparable periods of 2024. The decrease for the third quarter of 2025 primarily reflected lower third-party IP costs, and lower payments to the Israeli Innovation Authority of the Ministry of Economy and Industry in Israel (the IIA). The increase for the first nine months of 2025 principally reflected higher strategically beneficial customization and implementation work associated with the strategic 5G-Advanced deals we signed in the second half of 2024, partially offset by lower payments to the IIA. Included in cost of revenues for the third quarter and first nine months of 2025 was a non-cash equity-based compensation expense of $168,000 and $493,000, respectively, as compared to $176,000 and $570,000 for the comparable periods of 2024.

*Gross Margin*

Gross margin for the third quarter and first nine months of 2025 was 88% and 87%, respectively, as compared to 85% and 88% for the comparable periods of 2024. The increase for the third quarter of 2025 mainly reflected lower cost of revenues, as set forth above. The decrease for the first nine months of 2025 mainly reflected higher cost of revenues, as set forth above.

*Operating Expenses*

Total operating expenses were $27.1 million and $78.8 million for the third quarter and first nine months of 2025, respectively, as compared to $25.9 million and $75.9 million for the comparable periods of 2024. The net increase for the third quarter of 2025 principally reflected higher salaries and employee-related costs and higher non-cash equity-based compensation expenses, partially offset by lower allowance for credit losses. The net increase for the first nine months of 2025 principally reflected higher salaries and employee-related costs and higher non-cash equity-based compensation expenses, partially offset by higher allocation of customization and implementation work for our licensees to cost of revenues.

*Research and Development Expenses, Net*

Total research and development expenses, net were $19.5 million and $55.9 million for the third quarter and first nine months of 2025, respectively, as compared to $18.0 million and $54.7 million for the comparable periods of 2024. The increase for the third quarter of 2025 principally reflected higher salaries and employee-related costs. The increase for the first nine months of 2025 principally reflected higher salaries and employee-related costs and higher non-cash equity-based compensation expenses, partially offset by higher allocation of customization and implementation work for our licensees to cost of revenues. Included in research and development expenses for the third quarter and first nine months of 2025 were non-cash equity-based compensation expenses of $2,639,000 and $7,778,000, respectively, as compared to $2,421,000 and $6,866,000 for the comparable periods of 2024. Research and development expenses as a percentage of our total revenues were 69% and 71% for the third quarter and first nine months of 2025, as compared to 66% and 70% for the comparable periods of 2024. The percentage increase for both the third quarter and first nine months of 2025, as compared to the comparable periods of 2024, was mainly due to the same reasons as set forth above for the increase in research and development expenses.

The number of research and development personnel was 322 at September 30, 2025, as compared to 326 at September 30, 2024.

------

[**Table of Contents**](#toc)

*Sales and Marketing Expenses*

Our sales and marketing expenses were $3.0 million and $9.8 million for the third quarter and first nine months of 2025, respectively, as compared to $3.1 million and $9.0 million for the comparable periods of 2024. The increase for the first nine months of 2025 principally reflected higher salaries and employee-related costs, and higher non-cash equity-based compensation expenses. Included in sales and marketing expenses for the third quarter and first nine months of 2025 were non-cash equity-based compensation expenses of $571,000 and $1,735,000, respectively, as compared to $491,000 and $1,307,000 for the comparable periods of 2024. Sales and marketing expenses as a percentage of our total revenues were 11% and 12% for the third quarter and first nine months of 2025, respectively, as compared to 11% and 12% for the comparable periods of 2024.

The total number of sales and marketing personnel was 32 at both September 30, 2025, and 2024.

*General and Administrative Expenses*

Our general and administrative expenses were $4.4 million and $12.7 million for the third quarter and first nine months of 2025, respectively, as compared to $4.6 million and $11.8 million for the comparable periods of 2024. The decrease for the third quarter of 2025 primarily reflected lower allowance for credit losses, partially offset by higher non-cash equity-based compensation expenses. The increase for the first nine months of 2025 primarily reflected higher non-cash equity-based compensation expenses and higher professional services costs, partially offset by lower allowance for credit losses. Included in general and administrative expenses for the third quarter and first nine months of 2025 were non-cash equity-based compensation expenses of $1,495,000 and $4,092,000, respectively, as compared to $1,120,000 and $2,936,000 for the comparable periods of 2024. General and administrative expenses as a percentage of our total revenues were 15% and 16% for the third quarter and first nine months of 2025, respectively, as compared to 17% and 15% for the comparable periods of 2024.

The number of general and administrative personnel was 49 at September 30, 2025, as compared to 45 at September 30, 2024.

*Amortization of Intangible Assets*

Our amortization charges were $0.1 million and $0.4 million for the third quarter and first nine months of 2025, respectively, as compared to $0.1 million and $0.4 million for the comparable periods of 2024. The amortization charges for both the third quarter and first nine months of 2025 and 2024 were incurred in connection with the amortization of intangible assets associated with the acquisitions of the Hillcrest Labs and VisiSonics business.

***Financial Income, Net (in millions)***

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Nine** <br> **Months<br> 2025** | **Nine** <br> **Months<br> 2024** | **Third**<br> **Quarter<br> 2025** | **Third**<br> **Quarter<br> 2024** |
| **Financial income, net**  | $5.47 | $4.96 | $1.25 | $2.30 |
| ***of which:*** |  |  |  |  |
| Interest income and gains and losses from marketable securities, net | $4.56 | $4.44 | $1.51 | $1.50 |
| Foreign exchange gain (loss) | $0.91 | $0.52 | $(0.26) | $0.80 |

---

Financial income, net, consists of interest earned on investments, gains and losses from sale of marketable securities, accretion (amortization) of discounts (premiums) on marketable securities and foreign exchange movements.

The increase in interest income and gains and losses from marketable securities, net, during both the third quarter and first nine months of 2025 principally reflected higher yields, partially offset by lower combined bank deposits and marketable securities balances held.

We review our monthly expected major non-U.S. dollar denominated expenditures and look to hold equivalent non-U.S. dollar cash balances to mitigate currency fluctuations. However, our Euro cash balances increase significantly on a quarterly basis beyond our Euro liabilities, mainly from applicable French research tax credits, which are generally refunded every three years. This has resulted in a foreign exchange loss of $0.26 million and a foreign exchange gain of $0.91 million for the third quarter and first nine months of 2025, respectively, as compared to a foreign exchange gain of $0.80 million and $0.52 million for the comparable periods of 2024.

***Remeasurement of Marketable Equity Securities***

We recorded a gain of $1,000 and a loss of $261,000 for the third quarter and first nine months of 2025, respectively, as compared to a gain of $21,000 and a loss of $97,000 for the comparable periods of 2024, related to remeasurement of marketable equity securities, which we hold at fair value. Over time, other income (expense), net, may be affected by market dynamics and other factors. Equity values generally change daily for marketable equity securities and upon the occurrence of observable price changes or upon impairment of marketable equity securities. In addition, volatility in the global economic climate and financial markets could result in a significant change in the value of our investments.

------

[**Table of Contents**](#toc)

***Provision for Income Taxes***

Our income tax expenses was $1.7 million and $3.8 million for the third quarter and first nine months of 2025, respectively, as compared to $1.0 million and $4.3 million for the comparable periods of 2024. The increase for the third quarter of 2025 primarily reflected higher tax expenses on income generated in our French subsidiary (under the French IP Box regime). The decrease for the first nine months of 2025 primarily reflected lower withholding tax expenses in our Israeli subsidiary for which we will not be able to obtain a refund from the tax authorities.

We are subject to income and other taxes in the United States and in numerous foreign jurisdictions. Our domestic and foreign tax liabilities are dependent on the jurisdictions in which profits are determined to be earned and taxed. Additionally, the amount of taxes paid is subject to our interpretation of applicable tax laws in the jurisdictions in which we operate. A number of factors influence our effective tax rate, including changes in tax laws and treaties as well as the interpretation of existing laws and rules. Federal, state, and local governments and administrative bodies within the United States, and other foreign jurisdictions have implemented, or are considering, a variety of broad tax, trade, and other regulatory reforms that may impact us. On July 4, 2025, President Donald Trump signed the One Big Beautiful Bill Act ("OBBBA") into law, which is considered the enactment date under U.S. GAAP. Key corporate tax provisions of OBBBA include the restoration of 100% bonus depreciation, immediate expensing for domestic research and experimental expenditures, changes to Section 163(j) interest limitations, modification of several international tax provisions, and expanded Section 162(m) aggregation requirements. In accordance with ASC 740, we have recognized the effects of the new tax law in the period of enactment. The impact of OBBBA for the quarter ended September 30, 2025 did not have a material impact on our financial position for the period. We continue to evaluate the impact of OBBBA on our consolidated financial statements and will update its estimates as additional guidance becomes available.

We have significant operations in Israel and operations in France and the Republic of Ireland. A substantial portion of our taxable income is generated in Israel and France, as well as potentially in the U.S. due to GILTI and the requirement to capitalize research and development expenditures under IRC Section 174 over 15 years if sourced internationally. Although our Israeli, French and Irish subsidiaries are taxed at rates substantially lower than U.S. tax rates, the tax rates in these jurisdictions could nevertheless result in a substantial increase as a result of withholding tax expenses with respect to which we are unable to obtain a refund from the relevant tax authorities.

Our Irish subsidiary qualified for a 12.5% tax rate on its trade. Interest income generated by our Irish subsidiary is taxed at a rate of 25%.

Our French subsidiary is entitled to a tax benefit of 10% applied to specific revenues under the French IP Box regime. The French IP Box regime applies to net income derived from the licensing, sublicensing or sale of several IP rights such as patents and copyrighted software, including royalty revenues. This elective regime requires a direct link between the income benefiting from the preferential treatment and the research and development expenditures incurred and contributing to that income. Qualifying income may be taxed at a favorable 10% CIT rate (plus social surtax, hence 10.3% in total). Income not eligible for a tax benefit under the French IP Box regime is taxed at a regular rate of 25%.

Our Israeli subsidiary is entitled to various tax benefits as a technological enterprise. In December 2016, the Economic Efficiency Law (Legislative Amendments for Applying the Economic Policy for the 2017 and 2018 Budget Years), 2016, which includes the Amendment to the Law for the Encouragement of Capital Investments, 1959 (Amendment 73) (the "Amendment"), was published. The Amendment, among other things, prescribes special tax tracks for technological enterprises, which are subject to rules that were issued by the Minister of Finance in April 2017.

The tax track under the Amendment, which is applicable to our Israeli subsidiary, is the "Technological Preferred Enterprise". Technological Preferred Enterprise is an enterprise for which total consolidated revenues of its parent company and all subsidiaries are less than 10 billion New Israeli Shekel (NIS). A Technological Preferred Enterprise, as defined in the Amendment, that is located in the center of Israel (where our Israeli subsidiary is currently located), is taxed at a rate of 12% on profits deriving from IP. Any dividends distributed to "foreign companies", as defined in the Amendment, deriving from income from technological enterprises will be taxed at a rate of 4%.

***Critical Accounting Policies and Estimates***

Our consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States. The preparation of these consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and related disclosures. We evaluate our estimates and assumptions on an ongoing basis. Our estimates are based on historical experience and various other assumptions that we believe to be reasonable under the circumstances. Our actual results could differ from these estimates.

------

[**Table of Contents**](#toc)

We believe that the assumptions and estimates associated with revenue recognition, equity-based compensation and credit losses have the greatest potential impact on our consolidated financial statements. Therefore, we consider these to be our critical accounting policies and estimates.

See our Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on February 27, 2025, for a discussion of additional critical accounting policies and estimates. There have been no changes in our critical accounting policies as compared to what was previously disclosed in the Annual Report on Form 10-K for the year ended December 31, 2024.

**LIQUIDITY AND CAPITAL RESOURCES**

As of September 30, 2025, we had approximately $17.3 million in cash and cash equivalents, $2.8 million in bank deposits, and $132.0 million in marketable securities, totaling $152.1 million, as compared to $163.6 million at December 31, 2024. The decrease for the first nine months of 2025 principally reflected cash used in operating activities and funds used to repurchase 340,295 shares of common stock for an aggregate consideration of approximately $7.2 million, partially offset by cash proceeds from exercise of stock-based awards and our receipt of cash proceeds of $3.5 million in connection with the sale of Intrinsix that were released from escrow in the second quarter of 2025.

Out of total cash, cash equivalents, bank deposits and marketable securities of $152.1 million, $127.5 million was held by our foreign subsidiaries. Our intent is to permanently reinvest earnings of our foreign subsidiaries, and our current operating plans do not demonstrate a need to repatriate foreign earnings to fund our U.S. operations. However, if these funds were needed for our operations in the United States, we would be required to accrue and pay taxes to repatriate these funds. The determination of the amount of additional taxes related to the repatriation of these earnings is not practicable, as it may vary based on various factors such as the location of the cash and the effect of regulation in the various jurisdictions from which the cash would be repatriated.

During the first nine months of 2025, we invested $52.5 million of cash in bank deposits and marketable securities with maturities up to 36 months from the balance sheet date. In addition, during the same period, bank deposits and marketable securities were sold or redeemed for cash amounting to $65.1 million. All our marketable securities are classified as available-for-sale. The purchase and sale or redemption of available-for-sale marketable securities are considered part of investing cash flow. Available-for-sale marketable securities are stated at fair value, with unrealized gains and losses reported in accumulated other comprehensive income (loss), a separate component of stockholders' equity, net of taxes. Realized gains and losses on sales of investments, as determined on a specific identification basis, are included in the interim condensed consolidated statements of loss. The amount of credit losses recorded for the first nine months of 2025 was immaterial. For more information about our marketable securities, see Note 7 to the interim condensed consolidated financial statements for the three and nine months ended September 30, 2025.

Bank deposits are classified as short-term bank deposits and long-term bank deposits. Short-term bank deposits are deposits with maturities of more than three months but no longer than one year from the balance sheet date, whereas long-term bank deposits are deposits with maturities of more than one year as of the balance sheet date. Bank deposits are presented at their cost, including accrued interest, and purchases and sales are considered part of cash flows from investing activities.

*Operating Activities*

Cash used in operating activities for the first nine months of 2025 was $12.1 million and consisted of net loss of $9.5 million, adjustments for non-cash items of $15.7 million, and changes in operating assets and liabilities of $18.3 million. Adjustments for non-cash items primarily consisted of $3.1 million of depreciation and amortization of intangible assets, and $14.1 million of equity-based compensation expenses, partially offset by $1.1 million of unrealized foreign exchange gain. The decrease in operating assets and liabilities primarily consisted of an increase in trade receivables of $12.2 million, a decrease in accrued expenses and other payables of $0.9 million, a decrease in accrued payroll and related benefits of $4.2 million (mainly as a result of a yearly bonus payments), and a decrease in deferred revenues of $0.5 million.

Cash used in operating activities for the first nine months of 2024 was $4.6 million and consisted of net loss of $7.0 million, adjustments for non-cash items of $13.6 million, and changes in operating assets and liabilities of $11.2 million. Adjustments for non-cash items primarily consisted of $3.0 million of depreciation and amortization of intangible assets, and $11.7 million of equity-based compensation expenses, partially offset by $0.7 million of amortization of premiums on available-for-sale marketable securities and $0.5 million of unrealized foreign exchange gain. The decrease in operating assets and liabilities primarily consisted of an increase in trade receivables of $7.8 million, and an increase in prepaid expenses and other assets of $3.7 million (mainly related to unbilled receivables of $2.7 million classified as "other long-term assets" in the Interim Condensed Consolidated Balance Sheets).

------

[**Table of Contents**](#toc)

Cash flows from operating activities may vary significantly from quarter to quarter depending on the timing of our receipts and payments. Our ongoing cash outflows from operating activities principally relate to payroll-related costs and obligations under our property leases and design tool licenses. Our primary sources of cash inflows are receipts from our accounts receivable, to some extent, funding from research and development government grants and French research tax credits, and interest earned from our cash, deposits and marketable securities. The timing of receipts of accounts receivable from customers is based upon the completion of agreed milestones or agreed dates as set out in the contracts.

*Investing Activities*

Net cash provided by investing activities for the first nine months of 2025 was $14.6 million, compared to $1.1 million of net cash used in investing activities for the comparable period of 2024. We had a cash outflow of $49.8 million and a cash inflow of $63.1 million with respect to investments in marketable securities during the first nine months of 2025, as compared to a cash outflow of $41.3 million and a cash inflow of $34.4 million with respect to investments in marketable securities during the first nine months of 2024. For the first nine months of 2025, we had a net investment of $0.7 million in bank deposits, as compared to net proceeds of $8.0 million from bank deposits for the comparable period of 2024. We had a cash outflow of $1.4 million and $1.9 million during the first nine months of 2025 and 2024, respectively, from purchase of property and equipment. For the first nine months of 2025 and 2024, we had a cash inflow of $3.5 million and $0.5 million, respectively, in connection with the release of escrowed funds associated with the sale of Intrinsix. For the first nine months of 2024, we had a cash outflow of $0.8 million for the acquisition of a Greek-based company.

*Financing Activities*

Net cash used in financing activities for the first nine months of 2025 was $3.9 million, as compared to net cash used in financing activities in the amount of $4.6 million for the comparable period of 2024.

In August 2008, we announced that our board of directors approved a share repurchase program for up to one million shares of common stock pursuant to Rule 10b-18 of the Exchange Act, which was extended by an additional 7,800,000 shares collectively across further approvals in 2010, 2013, 2014, 2018, 2020, 2023 and November 2024. During the first nine months ended September 30, 2025, we repurchased 340,295 shares of common stock at an average purchase price of $21.01 per share for an aggregate purchase price of $7.2 million. During the first nine months ended September 30, 2024, we repurchased 343,604 shares of common stock at an average purchase price of $21.70 per share for an aggregate purchase price of $7.5 million. As of September 30, 2025, we had 684,486 shares available for repurchase.

During the first nine months of 2025, we received $3.2 million from the exercise of stock-based awards, as compared to $2.9 million received for the comparable period of 2024.

We believe that our cash and cash equivalents, short-term bank deposits and marketable securities, along with cash from operations, will provide sufficient capital to fund our operations for at least the next 12 months. We cannot provide assurances, however, that the underlying assumed levels of revenues and expenses will prove to be accurate.

In addition, as part of our business strategy, we occasionally evaluate potential acquisitions of businesses, products and technologies and minority equity investments. Accordingly, a portion of our available cash may be used at any time for the acquisition of complementary products or businesses or minority equity investments. Such potential transactions may require substantial capital resources, which may require us to seek additional debt or equity financing. We cannot assure you that we will be able to successfully identify suitable acquisition or investment candidates, complete acquisitions or investments, integrate acquired businesses into our current operations, or expand into new markets. Furthermore, we cannot provide assurances that additional financing will be available to us in any required time frame and on commercially reasonable terms, if at all.

*Contractual Obligations and Commitments*

We believe that our contractual obligations and commitments have not changed materially from those included in our Annual Report on Form 10-K for the year ended December 31, 2024.

---

| | |
|:---|:---|
| **Item 3.** | **QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK** |

---

A majority of our revenues and a portion of our expenses are transacted in U.S. dollars and our assets and liabilities together with our cash holdings are predominately denominated in U.S. dollars. However, the majority of our expenses are denominated in currencies other than the U.S. dollar, principally the NIS and the Euro. Increases in volatility of the exchange rates of currencies other than the U.S. dollar versus the U.S. dollar could have an adverse effect on the expenses and liabilities that we incur when remeasured into U.S. dollars. We review our monthly expected non-U.S. dollar denominated expenditures and look to hold equivalent non-U.S. dollar cash balances to mitigate currency fluctuations. However, our Euro cash balances increase significantly on a quarterly basis beyond our Euro liabilities, mainly from French research tax benefits applicable to the CIR, which is generally refunded every three years. This has resulted in a foreign exchange loss of $266,000 and a foreign exchange gain of $908,000 for the third quarter and first nine months of 2025, respectively, and a foreign exchange gain of $802,000 and $523,000 for the comparable periods of 2024.

------

[**Table of Contents**](#toc)

As a result of currency fluctuations and the remeasurement of non-U.S. dollar denominated expenditures to U.S. dollars for financial reporting purposes, we may experience fluctuations in our operating results on an annual and quarterly basis. To protect against the increase in value of forecasted foreign currency cash flow resulting from salaries paid in currencies other than the U.S. dollar during the year, we follow a foreign currency cash flow hedging program. We hedge portions of the anticipated payroll for our non-U.S. employees denominated in currencies other than the U.S. dollar for a period of one to twelve months with forward and option contracts. During the third quarter and first nine months of 2025, we recorded accumulated other comprehensive loss of $582,000 and accumulated other comprehensive gain $203,000, respectively, from our forward and option contracts, net of taxes, with respect to anticipated payroll expenses for our non-U.S. employees. During the third quarter and first nine months of 2024, we recorded accumulated other comprehensive loss of $20,000 and $966,000, respectively, from our forward and option contracts, net of taxes, with respect to anticipated payroll expenses for our non-U.S. employees. As of September 30, 2025, the amount of other comprehensive gain from our forward and option contracts, net of taxes, was $203,000, which will be recorded in the consolidated statements of income (loss) during the following one month. We recognized a net gain of $648,000 and $1,009,000 for the third quarter and first nine months of 2025, respectively, and a net gain of $160,000 and $767,000 for the comparable periods of 2024, related to forward and options contracts. We note that hedging transactions may not successfully mitigate losses caused by currency fluctuations. We expect to continue to experience the effect of exchange rate and currency fluctuations on an annual and quarterly basis.

The majority of our cash and cash equivalents are invested in high-grade certificates of deposits with major U.S., European and Israeli banks. Generally, cash and cash equivalents and bank deposits may be redeemed and therefore minimal credit risk exists with respect to them. Nonetheless, deposits with these banks exceed the Federal Deposit Insurance Corporation (FDIC) insurance limits or similar limits in foreign jurisdictions, to the extent such deposits are even insured in such foreign jurisdictions. While we monitor on a systematic basis the cash and cash equivalent balances in the operating accounts and adjust the balances as appropriate, these balances could be impacted if one or more of the financial institutions with which we deposit our funds fails or is subject to other adverse conditions in the financial or credit markets. To date, we have experienced no loss of principal or lack of access to our invested cash or cash equivalents; however, we can provide no assurance that access to our invested cash and cash equivalents will not be affected if the financial institutions that we hold our cash and cash equivalents fail.

We hold an investment portfolio consisting principally of corporate bonds. We have the ability to hold such investments until recovery of temporary declines in market value or maturity. As of September 30, 2025, the unrealized losses associated with our investments were approximately $6 thousand. As we tend to hold such bonds with unrealized losses to recovery, the allowance for credit losses was not material during the first nine months of 2025. However, we can provide no assurance that we will recover present declines in the market value of our investments.

Interest income and gains and losses from marketable securities, net, were $1.51 million and $4.56 million for the third quarter and first nine months of 2025, respectively, as compared to $1.50 million and $4.44 million for the comparable periods of 2024. The increase in interest income, and gains and losses from marketable securities, net, during both the third quarter and first nine months of 2025 principally reflected higher yields, partially offset by lower combined bank deposits and marketable securities balances held.

We are exposed primarily to fluctuations in the level of U.S. interest rates. To the extent that interest rates rise, fixed interest investments may be adversely impacted, whereas a decline in interest rates may decrease the anticipated interest income for variable rate investments. We typically do not attempt to reduce or eliminate our market exposures on our investment securities because the majority of our investments are short-term. We currently do not have any derivative instruments but may put them in place in the future. Fluctuations in interest rates within our investment portfolio have not had, and we do not currently anticipate such fluctuations will have, a material effect on our financial position on an annual or quarterly basis.

---

| | |
|:---|:---|
| **Item 4.** | **CONTROLS AND PROCEDURES** |

---

As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of September 30, 2025.

There has been no change in our internal control over financial reporting that occurred during our most recent fiscal quarter that has materially affected or is reasonably likely to materially affect our internal control over financial reporting.

**PART II OTHER INFORMATION**

---

| | |
|:---|:---|
| **Item 1** | **LEGAL PROCEEDINGS** |

---

We are subject to legal proceedings and claims that have not been fully resolved and that have arisen in the ordinary course of business. As of September 30, 2025, our interim condensed consolidated balance sheet includes a provision of approximately $300,000 for these matters. We are not a party to any other litigation or legal proceedings that we believe could reasonably be expected to have a material effect on our business, results of operations and financial condition.

------

[**Table of Contents**](#toc)

---

| | |
|:---|:---|
| **Item 1A** | **RISK FACTORS** |

---

We have not identified any material changes to the Risk Factors previously disclosed in Part I—Item IA—"Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, any one or more of which could, directly or indirectly, cause our actual financial condition and operating results to vary materially from past, or from anticipated future, financial condition and operating results, except as set forth below. Any of those factors, in whole or in part, could materially and adversely affect our business, financial condition, operating results and stock price. You should carefully consider the risks and uncertainties described in our Annual Report filed on Form 10-K for the fiscal year ended December 31, 2024, together with all of the other information in this Quarterly Report on Form 10-Q, including in "Part I—Item 2—"Management's Discussion and Analysis of Financial Condition and Results of Operations" and the condensed consolidated financial statements and related notes.

***Changes in the U.S. trade environment, including uncertainty over global tariffs and the financial impact of tariffs, as well as economic uncertainty associated with geopolitics, may negatively affect our business, financial condition and results of operations.***

The United States has enacted and proposed to enact significant new tariffs, as well as changes to existing tariffs. In addition, changes to U.S. trade policies, treaties and tariffs have resulted and may continue to result in retaliatory tariffs enacted by trading partners in response to such actions. Trade restrictions and rising political tensions could reduce trade volume, investment and other economic activities between major international economies, resulting in a material adverse effect on global economic conditions and the stability of global financial markets. Any of these factors could negatively impact our customers and other stakeholders. For example, these developments or a perception of these developments could cause our customers or potential customers to delay or re-evaluate their decisions to initiate various projects which in turn could result in a delay or cessation of engagement or other business activities with us, and which could result in lower licensing revenues. In addition, lower consumer demand may result in lower royalty revenues as our customers ship fewer units. All these developments could negatively impact our business, financial condition and results of operations, and may make it difficult for us to forecast and plan future budgetary decisions or business activities accurately.

------

[**Table of Contents**](#toc)

---

| | |
|:---|:---|
| **Item 2** | **UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS** |

---

The table below sets forth the information with respect to repurchases of our common stock during the three months ended September 30, 2025.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Period** | **(a) Total** <br> **Number of** <br> **Shares** <br> **Purchased**  | **(b) Average** <br> **Price** <br> **Paid per Share** | **(c) Total** <br> **Number**<br> **of Shares** <br> **Purchased as** <br> **Part**<br> **of Publicly**<br> **Announced** <br> **Plans** <br> **or Programs** | **(d) Maximum**<br> **Number of** <br> **Shares**<br> **that May Yet** <br> **Be**<br> **Purchased** <br> **Under** <br> **the Plans or**<br> **Programs (1)** |  |
| Month #1 (July 1, 2025 to July 31, 2025) |  |  |  | 724781 |  |
| Month #2 (August 1, 2025 to August 31, 2025) |  |  |  | 724781 |  |
| Month #3 (September 1, 2025 to September 30, 2025) | 40295 | $24.53 | 40295 | 684486 |  |
| TOTAL | 40295 | $24.53 | 40295 | 684, 486 | (2) |

---

(1) In August 2008, we announced that our board of directors approved a share repurchase program for up to one million shares of common stock pursuant to Rule 10b-18 of the Exchange Act, which was extended by an additional 7,800,000 shares collectively across further approvals in 2010, 2013, 2014, 2018, 2020, 2023 and November 2024.

(2) The number represents the number of shares of our common stock that remain available for repurchase pursuant to our share repurchase program.

---

| | |
|:---|:---|
| **Item 3** | **DEFAULTS UPON SENIOR SECURITIES** |

---

Not applicable.

---

| | |
|:---|:---|
| **Item 4** | **MINE SAFETY DISCLOSURES** |

---

Not applicable.

---

| | |
|:---|:---|
| **Item 5** | **OTHER INFORMATION** |

---

During the nine months ended September 30, 2025, no director or officer (as defined in Rule 16a-1(f) under the Exchange Act) of the Company adopted or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408 of Regulation S-K.

------

[**Table of Contents**](#toc)

---

| | |
|:---|:---|
| **Item 6** | **EXHIBITS** |

---

---

| | |
|:---|:---|
| Exhibit<br> No. | Description |
| 31.1 | [<u>Rule 13a14(a)/15d14(a) Certification of Chief Executive Officer.</u>](ex_884329.htm) |
| 31.2 | [<u>Rule 13a14(a)/15d14(a) Certification of Chief Financial Officer.</u>](ex_884330.htm) |
| 32 | [<u>Section 1350 Certification of Chief Executive Officer and Chief Financial Officer.</u>](ex_884331.htm) |
| 101 | The following materials from Ceva, Inc.'s Quarterly report on Form 10-Q for the quarter ended September 30, 2025, formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the Condensed Consolidated Statements of Loss, (ii) the Condensed Consolidated Balance Sheet, (iii) the Condensed Consolidated Statements of Cash Flows, (iv) the Condensed Consolidated Statements of Comprehensive Income (Loss), (v) Condensed Consolidated Statements of Changes in Stockholders' Equity, and (vi) Notes to Condensed Consolidated Financial Statements. |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | |
|:---|:---|
|  | Ceva, Inc. |
| Date: November 10, 2025 | By:&nbsp;&nbsp;&nbsp;&nbsp;/s/&nbsp;&nbsp;&nbsp;&nbsp;AMIR PANUSH |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Amir Panush<br> Chief Executive Officer<br> (principal executive officer) |
| Date: November 10, 2025 | By:&nbsp;&nbsp;&nbsp;&nbsp;/s/&nbsp;&nbsp;&nbsp;&nbsp;YANIV ARIELI |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Yaniv Arieli<br> Chief Financial Officer<br> (principal financial officer and principal accounting officer) |

---

## Exhibit 31.1

**EXHIBIT 31.1**

**CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO**

**SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002**

I, Amir Panush, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this Quarterly Report on Form 10-Q of Ceva, Inc. (the "Company");

&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a15(e) and 15d15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a15(f) and 15d15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 10, 2025

<u>/s/</u><u> </u><u> </u><u> </u><u> </u><u>AMIR PANUSH</u><br> Amir Panush<br> Chief Executive Officer<br>

## Exhibit 31.2

**EXHIBIT 31.2**

**CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO**

**SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002**

I, Yaniv Arieli, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this Quarterly Report on Form 10-Q of Ceva, Inc. (the "Company");

&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a15(e) and 15d15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a15(f) and 15d15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 10, 2025

<u>/s/</u><u> </u><u> </u><u> </u><u> </u><u>YANIV ARIELI</u><br> Yaniv Arieli<br> Chief Financial Officer<br>

## Ex-32

**Exhibit 32**

**CERTIFICATION**

**PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the quarterly report on Form 10-Q of Ceva, Inc. (the "Company") for the quarter ended September 30, 2025, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, Amir Panush, Chief Executive Officer of the Company, and Yaniv Arieli, Chief Financial Officer of the Company, each hereby certifies, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

This certification will not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section. This certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except to the extent that the Company specifically incorporates it by reference.

---

| | |
|:---|:---|
| Date: November 10, 2025 |  |
|  | <u>/s/</u><u> </u><u> </u><u> </u><u> </u><u>AMIR PANUSH</u> |
|  | Amir Panush |
|  | Chief Executive Officer |
|  | <u>/s/</u><u> </u><u> </u><u> </u><u> </u><u>YANIV ARIELI</u> |
|  | Yaniv Arieli |
|  | Chief Financial Officer |

---